A	O
serum	B-DNA
response	I-DNA
element	I-DNA
and	O
a	O
binding	B-DNA
site	I-DNA
for	I-DNA
NF-Y	I-DNA
mediate	O
the	O
serum	O
response	O
of	O
the	O
human	B-DNA
thrombospondin	I-DNA
1	I-DNA
gene	I-DNA
.	O

The	O
expression	O
of	O
thrombospondin	B-protein
1	I-protein
(	O
TSP	B-protein
1	I-protein
)	O
,	O
a	O
member	O
of	O
the	O
TSP	B-DNA
gene	I-DNA
family	I-DNA
,	O
is	O
rapidly	O
induced	O
by	O
growth	O
factors	O
.	O

We	O
tested	O
the	O
ability	O
of	O
human	B-DNA
TSP	I-DNA
1-chloramphenicol	I-DNA
acetyltransferase	I-DNA
constructs	I-DNA
to	O
respond	O
to	O
serum	O
in	O
stably	O
transfected	O
NIH-3T3	O
cells	O
.	O

Two	O
transcriptional	O
elements	O
in	O
the	O
TSP	B-protein
1	I-protein
promoter	O
,	O
a	O
distal	O
element	O
at	O
-1280	O
and	O
a	O
proximal	O
element	O
at	O
-65	O
,	O
were	O
required	O
for	O
the	O
response	O
of	O
the	O
human	O
TSP	O
1	O
gene	O
to	O
serum	O
.	O

The	O
distal	O
element	O
contains	O
the	O
5'-CC	O
(	O
A	O
+	O
T	O
)	O
6GG-3	O
'	O
consensus	O
sequence	O
characteristic	O
of	O
a	O
serum-response	O
element	O
(	O
SRE	O
)	O
.	O

Deletions	O
or	O
mutations	O
in	O
this	O
element	O
reduced	O
the	O
serum	O
response	O
of	O
the	O
TSP	B-DNA
1	I-DNA
gene	I-DNA
by	O
80-90	O
%	O
.	O

In	O
gel-shift	O
assays	O
,	O
the	O
-1280	B-DNA
element	I-DNA
and	O
the	O
c-fos	B-DNA
SRE	I-DNA
cross	I-DNA
-competed	O
,	O
whereas	O
their	O
functional	O
and	O
binding	B-DNA
mutants	I-DNA
did	O
not	O
.	O

The	O
proximal	B-DNA
element	I-DNA
contains	O
the	O
sequence	O
5'-GGCCAATGGG-3	O
'	O
,	O
which	O
closely	O
resembles	O
the	O
consensus	O
binding	O
motif	O
for	O
the	O
CCAAT-binding	B-DNA
factor	I-DNA
NF-Y	B-protein
(	O
CBF	B-protein
,	O
CP1	B-protein
,	O
alpha	B-protein
CP1	I-protein
)	O
.	O

Deletions	O
or	O
mutations	O
in	O
this	O
element	O
also	O
reduced	O
the	O
serum	O
response	O
by	O
80-90	O
%	O
.	O

Methylation	O
interference	O
analysis	O
of	O
the	O
-65	B-DNA
region	I-DNA
identified	O
a	O
pattern	O
of	O
contacts	O
with	O
nuclear	B-protein
factors	I-protein
resembling	O
that	O
for	O
NF-Y	B-protein
,	O
and	O
an	O
NF-Y-binding	B-DNA
site	I-DNA
and	O
the	O
proximal	B-DNA
TSP	I-DNA
1	I-DNA
element	I-DNA
cross-competed	O
in	O
gel-shift	O
assays	O
,	O
whereas	O
their	O
binding	B-DNA
mutants	I-DNA
did	O
not	O
.	O

Finally	O
,	O
an	O
abbreviated	B-DNA
TSP	I-DNA
1	I-DNA
promoter/5'-flank	I-DNA
,	O
containing	O
the	O
SRE-	B-DNA
and	I-DNA
NF-Y-binding	I-DNA
sites	I-DNA
,	O
mediated	O
a	O
serum	O
response	O
that	O
was	O
close	O
in	O
magnitude	O
to	O
that	O
of	O
the	O
parent	B-DNA
promoter	I-DNA
.	O

We	O
conclude	O
that	O
the	O
serum	O
response	O
of	O
the	O
human	O
TSP	B-DNA
1	I-DNA
gene	I-DNA
requires	O
the	O
coordinated	O
function	O
of	O
an	O
SRE-	B-DNA
and	I-DNA
NF-Y-binding	I-DNA
site	I-DNA
.	O

Tug	NULL
JourNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
R	NULL
©1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

268	NULL
,	NULL
No	NULL
.	NULL

7	NULL
,	NULL
Issue	NULL
of	NULL
March	NULL
5	NULL
,	NULL
pp	NULL
.	NULL

4989-4996	NULL
,	NULL
1993	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
A	NULL
Serum	NULL
Response	NULL
Element	NULL
and	NULL
a	NULL
Binding	NULL
Site	NULL
for	NULL
NF-Y	NULL
Mediate	NULL
the	NULL
Serum	NULL
Response	NULL
of	NULL
the	NULL
Human	NULL
Thrombospondin	NULL
1	NULL
Gene*	NULL
Paul	NULL
Framsont	NULL
and	NULL
Paul	NULL
Bornsteint§	NULL
!	NULL

(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
September	NULL
1	NULL
,	NULL
1992	NULL
)	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
{	NULL
Biochemistry	NULL
and	NULL
§Medicine	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
98195	NULL
The	NULL
expression	NULL
of	NULL
thrombospondin	NULL
1	NULL
(	NULL
TSP	NULL
1	NULL
)	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
TSP	NULL
gene	NULL
family	NULL
,	NULL
is	NULL
rapidly	NULL
induced	NULL
by	NULL
growth	NULL
factors	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
human	NULL
TSP	NULL
1-chloramphenicol	NULL
acetyltransferase	NULL
constructs	NULL
to	NULL
respond	NULL
to	NULL
serum	NULL
in	NULL
stably	NULL
transfected	NULL
NIH-3T3	NULL
cells	NULL
.	NULL

Two	NULL
transcriptional	NULL
elements	NULL
in	NULL
the	NULL
TSP	NULL
1	NULL
promoter	NULL
,	NULL
a	NULL
distal	NULL
element	NULL
at	NULL
-1280	NULL
and	NULL
a	NULL
proximal	NULL
element	NULL
at	NULL
-65	NULL
,	NULL
were	NULL
required	NULL
for	NULL
the	NULL
response	NULL
of	NULL
the	NULL
human	NULL
TSP	NULL
1	NULL
gene	NULL
to	NULL
serum	NULL
.	NULL

The	NULL
distal	NULL
element	NULL
contains	NULL
the	NULL
5'-CC	NULL
(	NULL
A	NULL
+	NULL
T	NULL
)	NULL
,	NULL
GG-3	NULL
'	NULL
consensus	NULL
sequence	NULL
characteristic	NULL
of	NULL
a	NULL
serum-response	NULL
element	NULL
(	NULL
SRE	NULL
)	NULL
.	NULL

Deletions	NULL
or	NULL
mutations	NULL
in	NULL
this	NULL
element	NULL
reduced	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
gene	NULL
by	NULL
80-90	NULL
%	NULL
.	NULL

In	NULL
gel-shift	NULL
assays	NULL
,	NULL
the	NULL
-1280	NULL
element	NULL
and	NULL
the	NULL
c-fos	NULL
SRE	NULL
cross-competed	NULL
,	NULL
whereas	NULL
their	NULL
functional	NULL
and	NULL
binding	NULL
mutants	NULL
did	NULL
not	NULL
.	NULL

The	NULL
proximal	NULL
element	NULL
contains	NULL
the	NULL
sequence	NULL
G-3	NULL
'	NULL
,	NULL
which	NULL
closely	NULL
resembles	NULL
the	NULL
consensus	NULL
binding	NULL
motif	NULL
for	NULL
the	NULL
CCAAT-binding	NULL
factor	NULL
NF-Y	NULL
(	NULL
CBF	NULL
,	NULL
CP1	NULL
,	NULL
a	NULL
«	NULL
CP1	NULL
)	NULL
}	NULL
.	NULL

Deletions	NULL
or	NULL
mutations	NULL
in	NULL
this	NULL
element	NULL
also	NULL
reduced	NULL
the	NULL
serum	NULL
response	NULL
by	NULL
80-90	NULL
%	NULL
.	NULL

Methylation	NULL
interference	NULL
analysis	NULL
of	NULL
the	NULL
-65	NULL
region	NULL
identified	NULL
a	NULL
pattern	NULL
of	NULL
contacts	NULL
with	NULL
nuclear	NULL
factors	NULL
resembling	NULL
that	NULL
for	NULL
NF-Y	NULL
,	NULL
and	NULL
an	NULL
NF-	NULL
Y-binding	NULL
site	NULL
and	NULL
the	NULL
proximal	NULL
TSP	NULL
1	NULL
element	NULL
cross-competed	NULL
in	NULL
gel-shift	NULL
assays	NULL
,	NULL
whereas	NULL
their	NULL
binding	NULL
mutants	NULL
did	NULL
not	NULL
.	NULL

Finally	NULL
,	NULL
an	NULL
abbreviated	NULL
TSP	NULL
1	NULL
promoter/5'-flank	NULL
,	NULL
containing	NULL
the	NULL
SRE-	NULL
and	NULL
NF-Y-binding	NULL
sites	NULL
,	NULL
mediated	NULL
a	NULL
serum	NULL
response	NULL
that	NULL
was	NULL
close	NULL
in	NULL
magnitude	NULL
to	NULL
that	NULL
of	NULL
the	NULL
parent	NULL
promoter	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
human	NULL
TSP	NULL
1	NULL
gene	NULL
requires	NULL
the	NULL
coordinated	NULL
function	NULL
of	NULL
an	NULL
SRE	NULL
-	NULL
and	NULL
NF-Y	NULL
-binding	NULL
site	NULL
.	NULL

Thrombospondin	NULL
(	NULL
TSP	NULL
)	NULL
is	NULL
a	NULL
trimeric	NULL
secreted	NULL
protein	NULL
,	NULL
originally	NULL
identified	NULL
as	NULL
an	NULL
abundant	NULL
constituent	NULL
of	NULL
platelet	NULL
a-granules	NULL
and	NULL
now	NULL
known	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
the	NULL
extracellular	NULL
matrix	NULL
and	NULL
cell	NULL
surfaces	NULL
of	NULL
diverse	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
fibroblasts	NULL
,	NULL
smooth	NULL
muscle	NULL
cells	NULL
,	NULL
and	NULL
glial	NULL
cells	NULL
.	NULL

Functions	NULL
for	NULL
TSP	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
blood	NULL
clotting	NULL
,	NULL
in	NULL
cell	NULL
attachment	NULL
,	NULL
migration	NULL
and	NULL
growth	NULL
,	NULL
in	NULL
neurite	NULL
outgrowth	NULL
,	NULL
and	NULL
in	NULL
control	NULL
of	NULL
angiogenesis	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

A	NULL
role	NULL
for	NULL
TSP	NULL
in	NULL
growth	NULL
of	NULL
smooth	NULL
muscle	NULL
cells	NULL
was	NULL
first	NULL
shown	NULL
by	NULL
its	NULL
ability	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
HL	NULL
18645	NULL
and	NULL
DFE	NULL
08229	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

«	NULL
Supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Training	NULL
Grant	NULL
HL	NULL
07312	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Bio-chemistry	NULL
,	NULL
SJ-70	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98195	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
206-543-1789	NULL
;	NULL
Fax	NULL
:	NULL
206-685-1792	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TSP	NULL
,	NULL
thrombospondin	NULL
;	NULL
SRE	NULL
,	NULL
serum	NULL
response	NULL
element	NULL
;	NULL
SRF	NULL
,	NULL
serum	NULL
response	NULL
factor	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
bGH	NULL
,	NULL
bovine	NULL
growth	NULL
hormone	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
.	NULL

to	NULL
enhance	NULL
epidermal	NULL
growth	NULL
factor-stimulated	NULL
DNA	NULL
synthesis	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
anti-TSP	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
shown	NULL
to	NULL
inhibit	NULL
entry	NULL
of	NULL
G	NULL
,	NULL
-arrested	NULL
smooth	NULL
muscle	NULL
cells	NULL
into	NULL
Gi	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
diversity	NULL
of	NULL
functions	NULL
ascribed	NULL
to	NULL
TSP	NULL
led	NULL
us	NULL
to	NULL
propose	NULL
that	NULL
,	NULL
for	NULL
some	NULL
cells	NULL
,	NULL
TSP	NULL
functions	NULL
as	NULL
an	NULL
extracellular	NULL
morphogen	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
proposal	NULL
,	NULL
TSP	NULL
could	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
dramatic	NULL
changes	NULL
in	NULL
cell	NULL
morphology	NULL
that	NULL
coincide	NULL
with	NULL
mitogenesis	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
identities	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
immediate	NULL
early	NULL
genes	NULL
(	NULL
see	NULL
below	NULL
)	NULL
suggest	NULL
a	NULL
program	NULL
of	NULL
mor-phogenetic	NULL
events	NULL
that	NULL
extends	NULL
from	NULL
the	NULL
extracellular	NULL
matrix	NULL
to	NULL
the	NULL
cytoskeleton	NULL
.	NULL

This	NULL
subset	NULL
includes	NULL
(	NULL
in	NULL
addition	NULL
to	NULL
TSP	NULL
)	NULL
the	NULL
extracellular	NULL
matrix	NULL
or	NULL
cell	NULL
surface-associated	NULL
proteins	NULL
,	NULL
fibronectin	NULL
and	NULL
cyr	NULL
61	NULL
,	NULL
the	NULL
integral	NULL
membrane	NULL
proteins	NULL
,	NULL
tissue	NULL
factor	NULL
and	NULL
the	NULL
a	NULL
and	NULL
$	NULL
subunits	NULL
of	NULL
fibronectin	NULL
integrin	NULL
,	NULL
and	NULL
the	NULL
cytoskeletal	NULL
proteins	NULL
,	NULL
G-actin	NULL
and	NULL
«	NULL
-tropomyosin	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
TSP	NULL
has	NULL
been	NULL
found	NULL
to	NULL
comprise	NULL
a	NULL
family	NULL
of	NULL
at	NULL
least	NULL
three	NULL
genes	NULL
:	NULL
TSP	NULL
1	NULL
,	NULL
TSP	NULL
2	NULL
,	NULL
and	NULL
TSP	NULL
3	NULL
(	NULL
1	NULL
,	NULL
10-12	NULL
)	NULL
.	NULL

We	NULL
(	NULL
13	NULL
)	NULL
and	NULL
others	NULL
(	NULL
14	NULL
)	NULL
have	NULL
previously	NULL
described	NULL
the	NULL
TSP	NULL
1	NULL
promoter	NULL
.	NULL

The	NULL
TSP	NULL
1	NULL
gene	NULL
is	NULL
clearly	NULL
growth-responsive	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
TSP	NULL
2	NULL
gene	NULL
is	NULL
either	NULL
nonresponsive	NULL
(	NULL
10	NULL
)	NULL
or	NULL
requires	NULL
stringent	NULL
conditions	NULL
of	NULL
quiescence	NULL
to	NULL
show	NULL
its	NULL
responsiveness	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
response	NULL
of	NULL
TSP	NULL
3	NULL
to	NULL
growth	NULL
factors	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
reported	NULL
.	NULL

This	NULL
study	NULL
addresses	NULL
the	NULL
basis	NULL
for	NULL
the	NULL
growth	NULL
responsiveness	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
gene	NULL
.	NULL

In	NULL
accord	NULL
with	NULL
its	NULL
ability	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
mitogenesis	NULL
of	NULL
some	NULL
cells	NULL
,	NULL
TSP	NULL
1	NULL
protein	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
,	NULL
mRNA	NULL
accumulation	NULL
(	NULL
15	NULL
,	NULL
16	NULL
,	NULL
20	NULL
)	NULL
,	NULL
mRNA	NULL
stability	NULL
(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
transcription	NULL
(	NULL
20	NULL
)	NULL
,	NULL
are	NULL
all	NULL
up-regulated	NULL
by	NULL
a	NULL
number	NULL
of	NULL
growth	NULL
factors	NULL
.	NULL

Furthermore	NULL
,	NULL
up-regulation	NULL
of	NULL
mRNA	NULL
levels	NULL
by	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
(	NULL
16	NULL
)	NULL
and	NULL
bovine	NULL
fibroblast	NULL
growth	NULL
factor	NULL
(	NULL
20	NULL
)	NULL
occurs	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
,	NULL
a	NULL
finding	NULL
that	NULL
demonstrates	NULL
independence	NULL
of	NULL
prior	NULL
protein	NULL
synthesis	NULL
and	NULL
qualifies	NULL
TSP	NULL
1	NULL
as	NULL
a	NULL
member	NULL
of	NULL
the	NULL
immediate	NULL
early	NULL
gene	NULL
family	NULL
.	NULL

Lau	NULL
and	NULL
Nathans	NULL
(	NULL
9	NULL
)	NULL
have	NULL
organized	NULL
the	NULL
immediate	NULL
early	NULL
genes	NULL
into	NULL
three	NULL
groups	NULL
according	NULL
to	NULL
the	NULL
kinetics	NULL
of	NULL
their	NULL
transcriptional	NULL
responses	NULL
to	NULL
growth	NULL
factors	NULL
and	NULL
subsequent	NULL
changes	NULL
in	NULL
mRNA	NULL
levels	NULL
.	NULL

Accordingly	NULL
,	NULL
group	NULL
I	NULL
genes	NULL
show	NULL
induction	NULL
of	NULL
mRNA	NULL
synthesis	NULL
within	NULL
5	NULL
min	NULL
of	NULL
growth	NULL
stimulation	NULL
.	NULL

Transcriptional	NULL
initiation	NULL
peaks	NULL
by	NULL
10-20	NULL
min	NULL
and	NULL
mRNA	NULL
levels	NULL
peak	NULL
within	NULL
an	NULL
hour	NULL
.	NULL

c-fos	NULL
is	NULL
a	NULL
prototypical	NULL
group	NULL
I	NULL
gene	NULL
.	NULL

Group	NULL
II	NULL
gene	NULL
mRNA	NULL
levels	NULL
peak	NULL
approximately	NULL
2	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
with	NULL
peak	NULL
transcriptional	NULL
initiation	NULL
occurring	NULL
between	NULL
1	NULL
and	NULL
2	NULL
h	NULL
post-stimulation	NULL
.	NULL

c-myc	NULL
is	NULL
a	NULL
prototypical	NULL
group	NULL
II	NULL
gene	NULL
.	NULL

Group	NULL
III	NULL
genes	NULL
show	NULL
changes	NULL
in	NULL
transcription	NULL
and	NULL
mRNA	NULL
accumulation	NULL
that	NULL
increase	NULL
more	NULL
slowly	NULL
and	NULL
persist	NULL
for	NULL
several	NULL
hours	NULL
,	NULL
beyond	NULL
the	NULL
times	NULL
when	NULL
groups	NULL
I	NULL
and	NULL
II	NULL
mRNAs	NULL
have	NULL
returned	NULL
to	NULL
preinduced	NULL
levels	NULL
.	NULL

Fibronectin	NULL
is	NULL
prototypical	NULL
for	NULL
group	NULL
III	NULL
.	NULL

TSP	NULL
1	NULL
displays	NULL
characteristics	NULL
that	NULL
are	NULL
intermediate	NULL
between	NULL
groups	NULL
I	NULL
and	NULL
III	NULL
.	NULL

Its	NULL
peak	NULL
transcriptional	NULL
initiation	NULL
,	NULL
from	NULL
10	NULL
to	NULL
30	NULL
min	NULL
post-stimulation	NULL
(	NULL
20	NULL
)	NULL
,	NULL
is	NULL
characteristic	NULL
of	NULL
group	NULL
I	NULL
genes	NULL
.	NULL

However	NULL
,	NULL
its	NULL
peak	NULL
mRNA	NULL
accumulation	NULL
at	NULL
3-4	NULL
°	NULL
P.	NULL
Framson	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

4989	NULL
4990	NULL
h	NULL
post-stimulation	NULL
(	NULL
15	NULL
,	NULL
16	NULL
,	NULL
20	NULL
)	NULL
and	NULL
its	NULL
4-8	NULL
h	NULL
mRNA	NULL
half-life	NULL
(	NULL
20	NULL
)	NULL
are	NULL
characteristic	NULL
of	NULL
group	NULL
III	NULL
genes	NULL
.	NULL

The	NULL
large	NULL
temporal	NULL
delay	NULL
between	NULL
the	NULL
peaks	NULL
of	NULL
transcriptional	NULL
initiation	NULL
and	NULL
mRNA	NULL
accumulation	NULL
for	NULL
TSP	NULL
1	NULL
could	NULL
be	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
long	NULL
mRNA	NULL
half-life	NULL
,	NULL
of	NULL
post-stimulation	NULL
increases	NULL
in	NULL
mRNA	NULL
half-life	NULL
(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
of	NULL
the	NULL
time	NULL
required	NULL
for	NULL
mRNA	NULL
elongation	NULL
of	NULL
an	NULL
18-kilobase	NULL
structural	NULL
gene	NULL
(	NULL
9	NULL
,	NULL
21	NULL
)	NULL
,	NULL
compared	NULL
with	NULL
that	NULL
for	NULL
c-fos	NULL
which	NULL
is	NULL
4	NULL
kilobases	NULL
.	NULL

The	NULL
kinetics-based	NULL
groupings	NULL
described	NULL
by	NULL
Lau	NULL
and	NULL
Nathans	NULL
(	NULL
9	NULL
)	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
augmented	NULL
in	NULL
the	NULL
future	NULL
by	NULL
a	NULL
classification	NULL
of	NULL
immediate	NULL
early	NULL
genes	NULL
according	NULL
to	NULL
the	NULL
underlying	NULL
pathways	NULL
involved	NULL
in	NULL
their	NULL
activation	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Lau	NULL
and	NULL
Nathans	NULL
(	NULL
9	NULL
)	NULL
observed	NULL
that	NULL
many	NULL
group	NULL
I	NULL
genes	NULL
,	NULL
but	NULL
not	NULL
all	NULL
,	NULL
have	NULL
either	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
transcriptionally	NULL
regulated	NULL
through	NULL
an	NULL
SRE	NULL
(	NULL
22	NULL
)	NULL
,	NULL
as	NULL
are	NULL
c-fos	NULL
,	NULL
G-actin	NULL
,	NULL
Krox	NULL
24	NULL
,	NULL
and	NULL
Krox	NULL
20	NULL
,	NULL
or	NULL
to	NULL
possess	NULL
an	NULL
SRE	NULL
motif	NULL
in	NULL
the	NULL
sequenced	NULL
regions	NULL
of	NULL
their	NULL
promoters	NULL
.	NULL

Indeed	NULL
,	NULL
a	NULL
sequence	NULL
closely	NULL
resembling	NULL
an	NULL
SRE	NULL
has	NULL
been	NULL
noted	NULL
in	NULL
the	NULL
promoter	NULL
for	NULL
human	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
and	NULL
mouse	NULL
(	NULL
21	NULL
)	NULL
TSP	NULL
1	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
explored	NULL
the	NULL
pro-moter/5	NULL
'	NULL
-flank	NULL
of	NULL
human	NULL
TSP	NULL
1	NULL
for	NULL
elements	NULL
that	NULL
mediate	NULL
its	NULL
response	NULL
to	NULL
calf	NULL
serum	NULL
.	NULL

We	NULL
identified	NULL
two	NULL
elements	NULL
,	NULL
one	NULL
of	NULL
which	NULL
is	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
an	NULL
SRE	NULL
,	NULL
and	NULL
the	NULL
other	NULL
is	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
CCAAT	NULL
motif-binding	NULL
factor	NULL
,	NULL
NF-Y	NULL
.	NULL

These	NULL
elements	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
TATA	NULL
box	NULL
region	NULL
,	NULL
mediate	NULL
the	NULL
response	NULL
of	NULL
the	NULL
human	NULL
TSP	NULL
1	NULL
promoter	NULL
to	NULL
serum	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Plasmids-All	NULL
plasmid	NULL
constructions	NULL
were	NULL
verified	NULL
by	NULL
restriction	NULL
analysis	NULL
,	NULL
and	NULL
in	NULL
cases	NULL
of	NULL
mutagenesis	NULL
,	NULL
by	NULL
partial	NULL
DNA	NULL
sequencing	NULL
.	NULL

Numerical	NULL
designations	NULL
for	NULL
TSP	NULL
1	NULL
sequences	NULL
are	NULL
as	NULL
described	NULL
in	NULL
Ref	NULL
.	NULL

13	NULL
.	NULL

The	NULL
parental	NULL
construct	NULL
,	NULL
-2033	NULL
CAT	NULL
,	NULL
contains	NULL
the	NULL
human	NULL
TSP	NULL
1	NULL
sequence	NULL
from	NULL
-2033	NULL
to	NULL
+750	NULL
and	NULL
has	NULL
been	NULL
described	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
following	NULL
members	NULL
of	NULL
a	NULL
5'-deletion	NULL
series	NULL
were	NULL
derived	NULL
by	NULL
religating	NULL
vectors	NULL
derived	NULL
from	NULL
-2033	NULL
CAT	NULL
after	NULL
the	NULL
following	NULL
treatment	NULL
:	NULL
1	NULL
)	NULL
-1539	NULL
CAT	NULL
,	NULL
Sall	NULL
and	NULL
Bsu836I	NULL
restriction	NULL
and	NULL
Klenow	NULL
fill-in	NULL
;	NULL
2	NULL
)	NULL
-1270	NULL
CAT	NULL
:	NULL
Sall	NULL
and	NULL
HindIII	NULL
restriction	NULL
and	NULL
Klenow	NULL
fill-in	NULL
;	NULL
3	NULL
)	NULL
-342	NULL
CAT	NULL
,	NULL
Pstl	NULL
and	NULL
Sacll	NULL
restriction	NULL
and	NULL
T4	NULL
polymerase	NULL
blunting	NULL
.	NULL

The	NULL
Sall	NULL
site	NULL
in	NULL
these	NULL
constructions	NULL
originates	NULL
from	NULL
the	NULL
vector	NULL
polylinker	NULL
sequence	NULL
5	NULL
'	NULL
to	NULL
the	NULL
PstI	NULL
site	NULL
at	NULL
-2033	NULL
.	NULL

-1290	NULL
CAT	NULL
was	NULL
derived	NULL
from	NULL
-2033	NULL
CAT	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
-1270	NULL
CAT	NULL
,	NULL
except	NULL
that	NULL
the	NULL
Klenow	NULL
step	NULL
was	NULL
eliminated	NULL
and	NULL
two	NULL
oligonucleotides	NULL
spanning	NULL
the	NULL
human	NULL
TSP	NULL
1	NULL
sequence	NULL
from	NULL
-1290	NULL
to	NULL
-1270	NULL
and	NULL
complementary	NULL
to	NULL
Sail	NULL
at	NULL
the	NULL
5'-end	NULL
and	NULL
HindIII	NULL
at	NULL
the	NULL
3'-end	NULL
,	NULL
were	NULL
annealed	NULL
and	NULL
included	NULL
in	NULL
the	NULL
ligation	NULL
.	NULL

The	NULL
two	NULL
oligonucleotides	NULL
are	NULL
5-TCGACTGAGATCCTTATTTGGTCA-3	NULL
'	NULL
and	NULL
5'-AGCTTGACCAAATAAGGATCTCAG-3	NULL
'	NULL
.	NULL

-2033	NULL
(	NULL
mut	NULL
-1280	NULL
)	NULL
CAT	NULL
was	NULL
derived	NULL
from	NULL
-2033	NULL
CAT	NULL
by	NULL
oligonucleotide-directed	NULL
mutagenesis	NULL
(	NULL
24	NULL
)	NULL
using	NULL
-2033	NULL
CAT	NULL
(	NULL
in	NULL
the	NULL
phagemid	NULL
pBS*	NULL
)	NULL
as	NULL
template	NULL
.	NULL

The	NULL
mutagenizing	NULL
oligonucleotide	NULL
was	NULL
3	NULL
'	NULL
in	NULL
which	NULL
the	NULL
underlined	NULL
``	NULL
T	NULL
``	NULL
represents	NULL
a	NULL
substitution	NULL
for	NULL
a	NULL
conserved	NULL
C	NULL
in	NULL
the	NULL
CArG	NULL
core	NULL
of	NULL
the	NULL
SRE	NULL
.	NULL

-89	NULL
CAT	NULL
was	NULL
derived	NULL
from	NULL
-342	NULL
CAT	NULL
in	NULL
the	NULL
following	NULL
way	NULL
.	NULL

A	NULL
vector	NULL
was	NULL
created	NULL
from	NULL
-342	NULL
CAT	NULL
by	NULL
excising	NULL
the	NULL
segment	NULL
between	NULL
-342	NULL
and	NULL
+166	NULL
by	NULL
Accl	NULL
restriction	NULL
followed	NULL
by	NULL
Klenow	NULL
fill-in	NULL
and	NULL
NotI	NULL
restriction	NULL
.	NULL

This	NULL
vector	NULL
was	NULL
then	NULL
ligated	NULL
to	NULL
a	NULL
-89	NULL
to	NULL
+166	NULL
fragment	NULL
derived	NULL
from	NULL
a	NULL
sequencing	NULL
deletion	NULL
template	NULL
(	NULL
13	NULL
)	NULL
by	NULL
EcoRI	NULL
restriction	NULL
followed	NULL
by	NULL
Klenow	NULL
fill-in	NULL
and	NULL
Nof	NULL
restriction	NULL
.	NULL

-38	NULL
CAT	NULL
was	NULL
derived	NULL
in	NULL
the	NULL
following	NULL
way	NULL
:	NULL
-1270/66	NULL
bGH	NULL
(	NULL
23	NULL
)	NULL
was	NULL
restricted	NULL
by	NULL
Bsml	NULL
(	NULL
at	NULL
-38	NULL
)	NULL
,	NULL
blunt-ended	NULL
with	NULL
T4	NULL
polymerase	NULL
,	NULL
and	NULL
digested	NULL
with	NULL
BamHI	NULL
(	NULL
at	NULL
the	NULL
human	NULL
TSP	NULL
1/bGH	NULL
junction	NULL
)	NULL
to	NULL
release	NULL
the	NULL
-38	NULL
to	NULL
+66	NULL
fragment	NULL
,	NULL
which	NULL
was	NULL
ligated	NULL
to	NULL
pBS*hGH	NULL
(	NULL
23	NULL
)	NULL
to	NULL
generate	NULL
-38/	NULL
66	NULL
bGH	NULL
.	NULL

This	NULL
product	NULL
was	NULL
then	NULL
restricted	NULL
with	NULL
PstI	NULL
(	NULL
in	NULL
the	NULL
polylinker	NULL
)	NULL
and	NULL
BssHII	NULL
to	NULL
liberate	NULL
the	NULL
-38	NULL
to	NULL
-23	NULL
fragment	NULL
.	NULL

-2033	NULL
CAT	NULL
was	NULL
treated	NULL
with	NULL
Pstl	NULL
and	NULL
BssHII	NULL
to	NULL
eliminate	NULL
the	NULL
-2033	NULL
to	NULL
-23	NULL
segment	NULL
and	NULL
to	NULL
produce	NULL
the	NULL
appropriate	NULL
vector	NULL
.	NULL

Finally	NULL
,	NULL
this	NULL
vector	NULL
was	NULL
ligated	NULL
to	NULL
the	NULL
-38	NULL
to	NULL
-23	NULL
fragment	NULL
.	NULL

-2033	NULL
(	NULL
A-238/-38	NULL
)	NULL
CAT	NULL
was	NULL
derived	NULL
by	NULL
ligating	NULL
a	NULL
vector	NULL
prepared	NULL
by	NULL
Sall	NULL
restriction	NULL
followed	NULL
with	NULL
Klenow	NULL
fill-in	NULL
and	NULL
Sacl	NULL
restriction	NULL
of	NULL
-38	NULL
CAT	NULL
,	NULL
to	NULL
a	NULL
fragment	NULL
generated	NULL
from	NULL
-2033	NULL
CAT	NULL
by	NULL
BssHII	NULL
restriction	NULL
(	NULL
at	NULL
-238	NULL
)	NULL
,	NULL
Klenow	NULL
fill-in	NULL
,	NULL
and	NULL
Sacl	NULL
restriction	NULL
.	NULL

-2033	NULL
(	NULL
A-238/-89	NULL
)	NULL
CAT	NULL
and	NULL
-2033	NULL
(	NULL
A-238/-89	NULL
;	NULL
mut	NULL
-65	NULL
)	NULL
CAT	NULL
were	NULL
derived	NULL
as	NULL
was	NULL
-2033	NULL
(	NULL
A-238/-38	NULL
)	NULL
CAT	NULL
,	NULL
except	NULL
that	NULL
their	NULL
parent	NULL
vectors	NULL
were	NULL
prepared	NULL
,	NULL
respectively	NULL
,	NULL
from	NULL
-89	NULL
CAT	NULL
and	NULL
-89	NULL
(	NULL
mut	NULL
Serum	NULL
Response	NULL
of	NULL
Thrombospondin	NULL
1	NULL
-65	NULL
)	NULL
CAT	NULL
(	NULL
see	NULL
below	NULL
)	NULL
by	NULL
Xbal	NULL
restriction	NULL
and	NULL
Klenow	NULL
fill-in	NULL
followed	NULL
by	NULL
SacI	NULL
restriction	NULL
.	NULL

-89	NULL
(	NULL
mut	NULL
-65	NULL
)	NULL
CAT	NULL
was	NULL
derived	NULL
in	NULL
the	NULL
following	NULL
way	NULL
.	NULL

A	NULL
polymerase	NULL
chain	NULL
reaction	NULL
product	NULL
was	NULL
generated	NULL
with	NULL
the	NULL
M13	NULL
universal	NULL
oligonucleotide	NULL
,	NULL
a	NULL
mutagenizing	NULL
oligonucleotide	NULL
,	NULL
and	NULL
a	NULL
sequencing	NULL
deletion	NULL
template	NULL
(	NULL
13	NULL
)	NULL
bearing	NULL
human	NULL
TSP	NULL
1	NULL
sequences	NULL
from	NULL
-2033	NULL
to	NULL
approximately	NULL
+30	NULL
.	NULL

The	NULL
mutagenizing	NULL
oligonucleotide	NULL
was	NULL
TAGAGTCGAATTCGCTTCCTGCCCGGCCGCCGAAGCTTCTT	NULL
GTAAGGAATCCCCAGGAATGCG-3	NULL
'	NULL
bearing	NULL
polylinker	NULL
Xbal	NULL
and	NULL
EcoRI	NULL
sites	NULL
at	NULL
its	NULL
5'-end	NULL
(	NULL
the	NULL
mutant	NULL
nucleotides	NULL
are	NULL
underlined	NULL
)	NULL
.	NULL

The	NULL
polymerase	NULL
chain	NULL
reaction	NULL
product	NULL
was	NULL
blunt-ended	NULL
with	NULL
T4	NULL
polymerase	NULL
,	NULL
kinased	NULL
,	NULL
and	NULL
ligated	NULL
,	NULL
and	NULL
restricted	NULL
with	NULL
Xbal	NULL
and	NULL
BssHII	NULL
to	NULL
generate	NULL
a	NULL
mutant	NULL
-89	NULL
to	NULL
-23	NULL
fragment	NULL
.	NULL

Finally	NULL
,	NULL
this	NULL
fragment	NULL
was	NULL
ligated	NULL
to	NULL
a	NULL
vector	NULL
prepared	NULL
by	NULL
Xbal	NULL
and	NULL
BssHII	NULL
restriction	NULL
of	NULL
-89	NULL
CAT	NULL
.	NULL

-1307	NULL
(	NULL
A-1228/-89	NULL
)	NULL
CAT	NULL
was	NULL
generated	NULL
by	NULL
ligating	NULL
a	NULL
fragment	NULL
whose	NULL
5'-end	NULL
is	NULL
the	NULL
HphI	NULL
site	NULL
at	NULL
-1307	NULL
blunt-ended	NULL
with	NULL
T4	NULL
DNA	NULL
polymerase	NULL
,	NULL
and	NULL
whose	NULL
3'-end	NULL
is	NULL
the	NULL
Eco47II1	NULL
site	NULL
at	NULL
-1228	NULL
,	NULL
to	NULL
a	NULL
vector	NULL
generated	NULL
from	NULL
-89	NULL
CAT	NULL
by	NULL
Xbal	NULL
restriction	NULL
and	NULL
Klenow	NULL
fill-in	NULL
.	NULL

T7ARsa	NULL
CAT	NULL
was	NULL
constructed	NULL
as	NULL
follows	NULL
:	NULL
-38/66	NULL
bGH	NULL
(	NULL
see	NULL
above	NULL
)	NULL
was	NULL
treated	NULL
with	NULL
Avel	NULL
and	NULL
Klenow	NULL
followed	NULL
by	NULL
HindIII	NULL
to	NULL
liberate	NULL
a	NULL
-38	NULL
to	NULL
15	NULL
fragment	NULL
for	NULL
ligation	NULL
into	NULL
a	NULL
vector	NULL
prepared	NULL
from	NULL
-1270	NULL
CAT	NULL
by	NULL
treatment	NULL
first	NULL
with	NULL
BamHI	NULL
and	NULL
Klenow	NULL
,	NULL
and	NULL
then	NULL
with	NULL
HindIl1	NULL
,	NULL
to	NULL
liberate	NULL
its	NULL
-1270	NULL
to	NULL
750	NULL
segment	NULL
.	NULL

The	NULL
product	NULL
,	NULL
-38	NULL
CAT	NULL
,	NULL
was	NULL
then	NULL
treated	NULL
with	NULL
PstI	NULL
and	NULL
Rsal	NULL
to	NULL
liberate	NULL
a	NULL
205-bp	NULL
fragment	NULL
bearing	NULL
TSP	NULL
1	NULL
intron	NULL
1	NULL
sequence	NULL
adjoining	NULL
150	NULL
bp	NULL
of	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
CAT	NULL
structural	NULL
gene	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
lastly	NULL
ligated	NULL
to	NULL
Smal-and	NULL
Pstl-restricted	NULL
pBS*	NULL
.	NULL

mTS6PPO.5	NULL
was	NULL
created	NULL
by	NULL
ligating	NULL
a	NULL
500-bp	NULL
Pstl	NULL
fragment	NULL
spanning	NULL
intron	NULL
4	NULL
and	NULL
parts	NULL
of	NULL
exons	NULL
4	NULL
and	NULL
5	NULL
of	NULL
mouse	NULL
TSP	NULL
1	NULL
(	NULL
23	NULL
)	NULL
into	NULL
the	NULL
PstI	NULL
site	NULL
of	NULL
pBS*	NULL
.	NULL

pKONeo	NULL
(	NULL
25	NULL
)	NULL
,	NULL
pUC119	NULL
bearing	NULL
the	NULL
SRE	NULL
,	NULL
and	NULL
pUC119	NULL
bearing	NULL
the	NULL
SRE	NULL
pm12	NULL
mutation	NULL
(	NULL
26	NULL
)	NULL
have	NULL
all	NULL
been	NULL
published	NULL
.	NULL

Cell	NULL
Culture	NULL
,	NULL
Transfection	NULL
,	NULL
and	NULL
Assays	NULL
of	NULL
Gene	NULL
Expression-NIH-3T3	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
+	NULL
10	NULL
%	NULL
calf	NULL
serum	NULL
.	NULL

For	NULL
the	NULL
serum	NULL
stimulation	NULL
assay	NULL
,	NULL
cells	NULL
were	NULL
plated	NULL
at	NULL
9	NULL
x	NULL
10°	NULL
cells/10-cm	NULL
dish	NULL
.	NULL

Approximately	NULL
40	NULL
h	NULL
later	NULL
they	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
warm	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
in	NULL
quiescence	NULL
medium	NULL
(	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
+	NULL
0.4	NULL
%	NULL
calf	NULL
serum	NULL
)	NULL
.	NULL

Stimulation	NULL
was	NULL
achieved	NULL
by	NULL
supplementing	NULL
the	NULL
quiescence	NULL
medium	NULL
with	NULL
15	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

All	NULL
media	NULL
were	NULL
supplemented	NULL
with	NULL
penicillin	NULL
,	NULL
streptomycin	NULL
,	NULL
and	NULL
butyl-p-hydroxy-benzoate	NULL
.	NULL

All	NULL
media	NULL
used	NULL
for	NULL
culture	NULL
of	NULL
stably	NULL
transfected	NULL
cells	NULL
were	NULL
supplemented	NULL
with	NULL
400	NULL
ug/ml	NULL
(	NULL
activity	NULL
)	NULL
Geneticin	NULL
(	NULL
Gibco	NULL
)	NULL
.	NULL

Stable	NULL
cell	NULL
populations	NULL
were	NULL
multiclonal	NULL
and	NULL
were	NULL
established	NULL
by	NULL
electroporating	NULL
the	NULL
TSP	NULL
1-CAT	NULL
constructs	NULL
,	NULL
together	NULL
with	NULL
pKONeo	NULL
,	NULL
at	NULL
a	NULL
mass	NULL
ratio	NULL
of	NULL
15:1	NULL
.	NULL

Gene	NULL
activities	NULL
in	NULL
stably	NULL
transfected	NULL
cells	NULL
were	NULL
assayed	NULL
by	NULL
RNase	NULL
protection	NULL
(	NULL
27	NULL
)	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
(	NULL
28	NULL
)	NULL
.	NULL

T7ARsa	NULL
CAT	NULL
and	NULL
mTS6PPOQ.5	NULL
(	NULL
see	NULL
above	NULL
)	NULL
were	NULL
used	NULL
to	NULL
generate	NULL
riboprobes	NULL
to	NULL
assay	NULL
the	NULL
transgene	NULL
and	NULL
endogenous	NULL
gene	NULL
mRNAs	NULL
,	NULL
respectively	NULL
.	NULL

T7ARsa	NULL
CAT	NULL
protected	NULL
150	NULL
bases	NULL
within	NULL
the	NULL
coding	NULL
part	NULL
of	NULL
the	NULL
CAT	NULL
transgene	NULL
mRNA	NULL
,	NULL
whereas	NULL
mTS6PPO.5	NULL
protected	NULL
181	NULL
bases	NULL
and	NULL
90	NULL
bases	NULL
of	NULL
exons	NULL
5	NULL
and	NULL
4	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
mouse	NULL
TSP	NULL
1	NULL
.	NULL

Since	NULL
specific	NULL
mRNA	NULL
levels	NULL
in	NULL
quiescent	NULL
cells	NULL
were	NULL
very	NULL
low	NULL
and	NULL
,	NULL
in	NULL
some	NULL
cases	NULL
,	NULL
very	NULL
high	NULL
in	NULL
serum-stimulated	NULL
cells	NULL
,	NULL
we	NULL
optimized	NULL
quantitation	NULL
by	NULL
synthesis	NULL
of	NULL
riboprobes	NULL
with	NULL
[	NULL
*P	NULL
]	NULL
CTP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
!	NULL
)	NULL

and	NULL
by	NULL
quantitation	NULL
of	NULL
gels	NULL
by	NULL
imaging	NULL
with	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
Model	NULL
4005s	NULL
Phosphorimager	NULL
.	NULL

Analysis	NULL
of	NULL
DNA-Nuclear	NULL
Factor	NULL
Binding-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
NIH-3T3	NULL
cells	NULL
as	NULL
described	NULL
in	NULL
Ref	NULL
.	NULL

29	NULL
.	NULL

For	NULL
gel	NULL
shift	NULL
,	NULL
8-10	NULL
ug	NULL
of	NULL
extract	NULL
were	NULL
incubated	NULL
with	NULL
specific	NULL
and	NULL
nonspecific	NULL
DNA	NULL
in	NULL
20	NULL
ul	NULL
of	NULL
nuclear	NULL
dialysis	NULL
buffer	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Extract	NULL
was	NULL
incubated	NULL
with	NULL
nonspecific	NULL
DNA	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Probe	NULL
and	NULL
specific	NULL
competitor	NULL
(	NULL
when	NULL
appropriate	NULL
)	NULL
were	NULL
added	NULL
and	NULL
incubated	NULL
an	NULL
additional	NULL
25	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Gel-shift	NULL
reactions	NULL
were	NULL
electro-phoresed	NULL
at	NULL
room	NULL
temperature	NULL
on	NULL
4	NULL
%	NULL
30:1	NULL
polyacrylamide-bis	NULL
gels	NULL
buffered	NULL
with	NULL
0.045	NULL
m	NULL
Tris	NULL
borate	NULL
,	NULL
0.001	NULL
M	NULL
EDTA	NULL
.	NULL

Methylation	NULL
interference	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
Maxam	NULL
and	NULL
Gilbert	NULL
sequencing	NULL
protocol	NULL
as	NULL
described	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Probe-specific	NULL
binding	NULL
conditions	NULL
(	NULL
in	NULL
addition	NULL
to	NULL
nuclear	NULL
dialysis	NULL
buffer	NULL
composition	NULL
(	NULL
29	NULL
)	NULL
)	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
TSP	NULL
1	NULL
-1280	NULL
,	NULL
c-fos	NULL
SRE	NULL
,	NULL
TSP	NULL
1	NULL
-65	NULL
,	NULL
NF-Y	NULL
and	NULL
SP1	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
calf	NULL
thymus	NULL
DNA/20	NULL
Ll	NULL
;	NULL
CTF	NULL
,	NULL
50	NULL
mM	NULL
KCl	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
calf	NULL
thymus	NULL
DNA/20	NULL
Ll	NULL
;	NULL
and	NULL
,	NULL
C/EBP	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
20	NULL
ul	NULL
.	NULL

Gel-shift	NULL
assay	NULL
with	NULL
CP2	NULL
as	NULL
probe	NULL
utilized	NULL
a	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
(	NULL
30	NULL
)	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
/	NULL
20	NULL
ul	NULL
.	NULL

The	NULL
calf	NULL
thymus	NULL
DNA	NULL
used	NULL
in	NULL
these	NULL
assays	NULL
was	NULL
prepared	NULL
by	NULL
shearing	NULL
and	NULL
boiling	NULL
.	NULL

Cloned	NULL
DNA	NULL
gel-shift	NULL
probes	NULL
and	NULL
competitors	NULL
are	NULL
as	NULL
follows	NULL
.	NULL

The	NULL
TSP	NULL
1	NULL
-1280	NULL
fragment	NULL
extends	NULL
from	NULL
-1307	NULL
to	NULL
-1228	NULL
and	NULL
was	NULL
prepared	NULL
from	NULL
-1307	NULL
(	NULL
A-1228/-89	NULL
)	NULL
CAT	NULL
(	NULL
see	NULL
above	NULL
)	NULL
by	NULL
restriction	NULL
Serum	NULL
Response	NULL
of	NULL
Thrombospondin	NULL
1	NULL
with	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
.	NULL

The	NULL
TSP	NULL
1	NULL
-1280	NULL
mutant	NULL
fragment	NULL
also	NULL
extends	NULL
from	NULL
-1307	NULL
to	NULL
-1228	NULL
and	NULL
was	NULL
prepared	NULL
from	NULL
-2033	NULL
(	NULL
mut	NULL
-1280	NULL
)	NULL
CAT	NULL
by	NULL
HphI	NULL
and	NULL
Eco47III	NULL
restriction	NULL
.	NULL

The	NULL
c-fos	NULL
SRE	NULL
fragment	NULL
and	NULL
the	NULL
c-fos	NULL
SRE	NULL
mutant	NULL
fragment	NULL
were	NULL
prepared	NULL
by	NULL
HindIII	NULL
and	NULL
EcoRI	NULL
restriction	NULL
of	NULL
pUC119	NULL
bearing	NULL
the	NULL
SRE	NULL
and	NULL
pUC119	NULL
bearing	NULL
the	NULL
SRE	NULL
pM12	NULL
mutation	NULL
,	NULL
respectively	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
TSP	NULL
1	NULL
-65	NULL
fragment	NULL
and	NULL
the	NULL
TSP	NULL
-65	NULL
mutant	NULL
fragment	NULL
were	NULL
prepared	NULL
by	NULL
Xbal	NULL
and	NULL
Bsml	NULL
restriction	NULL
of	NULL
-89	NULL
CAT	NULL
and	NULL
-89	NULL
(	NULL
mut	NULL
-65	NULL
)	NULL
CAT	NULL
,	NULL
respectively	NULL
.	NULL

For	NULL
preparation	NULL
of	NULL
gel	NULL
shift	NULL
probes	NULL
the	NULL
appropriately	NULL
restricted	NULL
plasmids	NULL
were	NULL
radiolabeled	NULL
with	NULL
T4	NULL
polymerase	NULL
or	NULL
Klenow	NULL
prior	NULL
to	NULL
gel	NULL
purification	NULL
.	NULL

Oligonucleotide-derived	NULL
binding	NULL
elements	NULL
were	NULL
generated	NULL
as	NULL
follows	NULL
.	NULL

NF-Y	NULL
and	NULL
NF-Y	NULL
mutant	NULL
are	NULL
34-mers	NULL
corresponding	NULL
to	NULL
nucleotides	NULL
-71	NULL
to	NULL
-38	NULL
of	NULL
the	NULL
Ea	NULL
gene	NULL
(	NULL
31	NULL
)	NULL
,	NULL
except	NULL
that	NULL
the	NULL
NF-Y	NULL
mutant	NULL
contains	NULL
a	NULL
CCAAT	NULL
to	NULL
CCAAA	NULL
mutation	NULL
.	NULL

SP1	NULL
is	NULL
the	NULL
high-affinity	NULL
SP1-binding	NULL
site	NULL
in	NULL
the	NULL
first	NULL
intron	NULL
of	NULL
«	NULL
1	NULL
type	NULL
I	NULL
collagen	NULL
(	NULL
30	NULL
)	NULL
.	NULL

CTF	NULL
is	NULL
the	NULL
CTF/NF1	NULL
binding	NULL
element	NULL
in	NULL
Ref	NULL
.	NULL

32	NULL
except	NULL
that	NULL
it	NULL
is	NULL
extended	NULL
on	NULL
the	NULL
5'-end	NULL
of	NULL
each	NULL
strand	NULL
with	NULL
GG	NULL
dinucleotides	NULL
.	NULL

C/EBP	NULL
is	NULL
as	NULL
in	NULL
Ref	NULL
.	NULL

33	NULL
.	NULL

CP2	NULL
is	NULL
as	NULL
in	NULL
Ref	NULL
.	NULL

34	NULL
except	NULL
that	NULL
the	NULL
sequence	NULL
conforms	NULL
precisely	NULL
with	NULL
the	NULL
mouse	NULL
-globin	NULL
gene	NULL
between	NULL
-95	NULL
and	NULL
-125	NULL
.	NULL

These	NULL
oligonucleotides	NULL
were	NULL
all	NULL
purified	NULL
on	NULL
polyacrylamide	NULL
gels	NULL
before	NULL
use	NULL
.	NULL

When	NULL
used	NULL
as	NULL
gel-shift	NULL
probes	NULL
,	NULL
oligonucleotides	NULL
were	NULL
labeled	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
or	NULL
Klenow	NULL
,	NULL
and	NULL
then	NULL
repurified	NULL
on	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

RESULTS	NULL
Two	NULL
Regions	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
Promoter/5'-Flank	NULL
,	NULL
between	NULL
-1290	NULL
and	NULL
-1270	NULL
and	NULL
between	NULL
-89	NULL
and	NULL
-38	NULL
,	NULL
Display	NULL
Serum-regulated	NULL
Function-We	NULL
initially	NULL
attempted	NULL
to	NULL
devise	NULL
an	NULL
assay	NULL
of	NULL
serum	NULL
regulation	NULL
in	NULL
transient	NULL
expression	NULL
,	NULL
as	NULL
was	NULL
first	NULL
reported	NULL
for	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
3-6-fold	NULL
induction	NULL
by	NULL
serum	NULL
of	NULL
the	NULL
transfected	NULL
-2033	NULL
CAT	NULL
construct	NULL
,	NULL
obtained	NULL
with	NULL
this	NULL
assay	NULL
,	NULL
was	NULL
too	NULL
small	NULL
and	NULL
variable	NULL
for	NULL
identification	NULL
of	NULL
cis-regulatory	NULL
elements	NULL
.	NULL

The	NULL
approach	NULL
that	NULL
ultimately	NULL
succeeded	NULL
relied	NULL
upon	NULL
identification	NULL
of	NULL
a	NULL
strain	NULL
of	NULL
NIH-3T3	NULL
cells	NULL
in	NULL
which	NULL
the	NULL
endogenous	NULL
mouse	NULL
TSP	NULL
1	NULL
gene	NULL
was	NULL
induced	NULL
roughly	NULL
100-fold	NULL
by	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

This	NULL
strain	NULL
became	NULL
the	NULL
parent	NULL
cell	NULL
line	NULL
for	NULL
stable	NULL
expression	NULL
of	NULL
-2033	NULL
CAT	NULL
and	NULL
its	NULL
derivatives	NULL
.	NULL

Fig	NULL
.	NULL

1A	NULL
shows	NULL
a	NULL
representative	NULL
time	NULL
course	NULL
of	NULL
changes	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
-2033	NULL
CAT	NULL
and	NULL
the	NULL
endogenous	NULL
mouse	NULL
TSP	NULL
1	NULL
mRNAs	NULL
,	NULL
determined	NULL
by	NULL
ribonuclease	NULL
protection	NULL
after	NULL
serum	NULL
stimulation	NULL
of	NULL
these	NULL
NIH-3T3	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
are	NULL
depicted	NULL
graphically	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

The	NULL
behavior	NULL
of	NULL
the	NULL
transgene	NULL
and	NULL
that	NULL
of	NULL
the	NULL
endogenous	NULL
gene	NULL
were	NULL
similar	NULL
during	NULL
the	NULL
first	NULL
2	NULL
h	NULL
of	NULL
serum	NULL
stimulation	NULL
.	NULL

This	NULL
close	NULL
parallel	NULL
provides	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
functional	NULL
assay	NULL
for	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
gene	NULL
.	NULL

The	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
transgene	NULL
is	NULL
defined	NULL
as	NULL
the	NULL
fold	NULL
response	NULL
of	NULL
the	NULL
transgene	NULL
mRNA	NULL
,	NULL
divided	NULL
by	NULL
the	NULL
fold	NULL
response	NULL
of	NULL
the	NULL
endogenous	NULL
gene	NULL
mRNA	NULL
,	NULL
at	NULL
2	NULL
h.	NULL
For	NULL
the	NULL
-2033	NULL
CAT	NULL
transgene	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
the	NULL
serum	NULL
response	NULL
is	NULL
approximately	NULL
1.0	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
presents	NULL
the	NULL
serum	NULL
responses	NULL
of	NULL
members	NULL
of	NULL
a	NULL
5'-deletion	NULL
series	NULL
derived	NULL
from	NULL
-2033	NULL
CAT	NULL
.	NULL

These	NULL
serum	NULL
responses	NULL
fell	NULL
,	NULL
with	NULL
one	NULL
exception	NULL
,	NULL
into	NULL
two	NULL
categories	NULL
:	NULL
approximately	NULL
1	NULL
and	NULL
0.15	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
deletion	NULL
series	NULL
that	NULL
contained	NULL
at	NULL
least	NULL
1290	NULL
bp	NULL
of	NULL
5	NULL
'	NULL
-flanking	NULL
DNA	NULL
showed	NULL
serum	NULL
responses	NULL
of	NULL
about	NULL
1	NULL
;	NULL
those	NULL
containing	NULL
5'-flanking	NULL
DNA	NULL
of	NULL
1270	NULL
bp	NULL
or	NULL
less	NULL
showed	NULL
serum	NULL
responses	NULL
of	NULL
about	NULL
0.15	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
region	NULL
between	NULL
-1290	NULL
and	NULL
-1270	NULL
mediates	NULL
serum-regulated	NULL
function	NULL
.	NULL

The	NULL
shortest	NULL
member	NULL
of	NULL
the	NULL
series	NULL
,	NULL
-38	NULL
CAT	NULL
,	NULL
showed	NULL
a	NULL
serum	NULL
response	NULL
which	NULL
appeared	NULL
to	NULL
be	NULL
less	NULL
than	NULL
0.15	NULL
,	NULL
a	NULL
finding	NULL
that	NULL
suggested	NULL
a	NULL
serum-regulated	NULL
function	NULL
for	NULL
the	NULL
region	NULL
between	NULL
-89	NULL
and	NULL
-38	NULL
.	NULL

Construction	NULL
of	NULL
a	NULL
pair	NULL
of	NULL
plasmids	NULL
with	NULL
internal	NULL
deletions	NULL
spanning	NULL
this	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lines	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
enabled	NULL
us	NULL
to	NULL
determine	NULL
the	NULL
influence	NULL
of	NULL
this	NULL
region	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
full	NULL
promoter/5'-flank	NULL
.	NULL

The	NULL
A-238/-38	NULL
promoter	NULL
deletion	NULL
reduced	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
to	NULL
about	NULL
0.15	NULL
;	NULL
however	NULL
,	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
with	NULL
the	NULL
A-238/-89	NULL
internal	NULL
promoter	NULL
deletion	NULL
was	NULL
about	NULL
4991	NULL
Hours	NULL
after	NULL
A.	NULL
serum	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
stimulation	NULL
ug	NULL
RNA/lane	NULL
35	NULL
.	NULL

|	NULL
3.3	NULL
3.3	NULL
3.3	NULL
3.3	NULL
3.3	NULL
n	NULL
»	NULL
xcar	NULL
*	NULL
fouls	NULL
-	NULL
4	NULL
Endogenous	NULL
TSP	NULL
1	NULL
we	NULL
w	NULL
un	NULL
120	NULL
-	NULL
B	NULL
.	NULL

-m-	NULL
-2033	NULL
CAT	NULL
1007	NULL
Endogenous	NULL
~®-	NULL
Tsp	NULL
I	NULL
~	NULL
]	NULL
S	NULL
so-3	NULL
h-.5	NULL
3	NULL
60-4	NULL
A	NULL
&	NULL
$	NULL
<	NULL
*	NULL
£	NULL
20	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Hours	NULL
after	NULL
serum	NULL
stimulation	NULL
wa	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

A	NULL
representative	NULL
time	NULL
course	NULL
of	NULL
serum	NULL
induction	NULL
of	NULL
mRNAs	NULL
from	NULL
stably	NULL
integrated	NULL
human	NULL
TSP	NULL
1	NULL
-2033	NULL
CAT	NULL
,	NULL
and	NULL
from	NULL
the	NULL
endogenous	NULL
mouse	NULL
TSP	NULL
1	NULL
gene	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
.	NULL

The	NULL
RNase	NULL
protection	NULL
assay	NULL
in	NULL
A	NULL
is	NULL
depicted	NULL
graphically	NULL
in	NULL
B	NULL
.	NULL

The	NULL
asterisk	NULL
in	NULL
A	NULL
indicates	NULL
incompletely	NULL
spliced	NULL
precursors	NULL
of	NULL
endogenous	NULL
TSP	NULL
1	NULL
mRNA	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Approximately	NULL
10-fold	NULL
more	NULL
RNA	NULL
was	NULL
loaded	NULL
in	NULL
the	NULL
0-h	NULL
lanes	NULL
.	NULL

Construct	NULL
Serum	NULL
Response	NULL
1	NULL
)	NULL
2033	NULL
CAT	NULL
1.0	NULL
+/-	NULL
0.3	NULL
(	NULL
10	NULL
)	NULL
2	NULL
)	NULL
1539	NULL
CAT	NULL
1.2	NULL
+/-	NULL
0.4	NULL
(	NULL
7	NULL
)	NULL
3	NULL
)	NULL
-1290	NULL
CAT	NULL
CO	NULL
0.93	NULL
+/-	NULL
0.44	NULL
(	NULL
6	NULL
)	NULL
4	NULL
)	NULL
-1270	NULL
CAT	NULL
C_	NULL
Es	NULL
:	NULL
]	NULL
0.14	NULL
+/-	NULL
0.01	NULL
(	NULL
8	NULL
)	NULL
5	NULL
)	NULL
-	NULL
342	NULL
CAT	NULL
0.13	NULL
+/-	NULL
0.04	NULL
(	NULL
3	NULL
)	NULL
342	NULL
6	NULL
)	NULL
_	NULL
89	NULL
CAT	NULL
0.15	NULL
+/-	NULL
0.07	NULL
(	NULL
7	NULL
)	NULL
89	NULL
m	NULL
--	NULL
38	NULL
Cat	NULL
0.07	NULL
+/-	NULL
0.03	NULL
(	NULL
3	NULL
)	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Serum	NULL
responses	NULL
of	NULL
members	NULL
of	NULL
a	NULL
5	NULL
'	NULL
deletion	NULL
series	NULL
of	NULL
human	NULL
TSP	NULL
1-CAT	NULL
transgenes	NULL
,	NULL
stably	NULL
expressed	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
.	NULL

The	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
transgene	NULL
is	NULL
defined	NULL
as	NULL
the	NULL
fold	NULL
response	NULL
of	NULL
the	NULL
transgene	NULL
mRNA	NULL
divided	NULL
by	NULL
the	NULL
fold	NULL
response	NULL
of	NULL
the	NULL
endogenous	NULL
gene	NULL
mRNA	NULL
,	NULL
at	NULL
2	NULL
h.	NULL
Values	NULL
in	NULL
parentheses	NULL
indicate	NULL
numbers	NULL
of	NULL
determinations	NULL
.	NULL

Elongated	NULL
ovals	NULL
,	NULL
transcriptional	NULL
elements	NULL
identified	NULL
in	NULL
this	NULL
study	NULL
;	NULL
filled	NULL
rectangle	NULL
,	NULL
human	NULL
TSP	NULL
1	NULL
first	NULL
exon	NULL
;	NULL
open	NULL
rectangle	NULL
,	NULL
CAT	NULL
structural	NULL
gene	NULL
.	NULL

The	NULL
entire	NULL
human	NULL
TSP	NULL
1	NULL
first	NULL
intron	NULL
separates	NULL
the	NULL
1st	NULL
exon	NULL
and	NULL
CAT	NULL
structural	NULL
gene	NULL
.	NULL

4992	NULL
equal	NULL
to	NULL
that	NULL
of	NULL
-2033	NULL
CAT	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
-89	NULL
to	NULL
-38	NULL
region	NULL
is	NULL
the	NULL
serum-responsive	NULL
subregion	NULL
of	NULL
the	NULL
-238	NULL
to	NULL
-38	NULL
sequence	NULL
and	NULL
has	NULL
an	NULL
influence	NULL
on	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
TSP1	NULL
gene	NULL
that	NULL
is	NULL
equal	NULL
in	NULL
magnitude	NULL
to	NULL
that	NULL
of	NULL
the	NULL
region	NULL
between	NULL
-1290	NULL
and	NULL
-1270	NULL
.	NULL

-1307	NULL
(	NULL
A-1228/-89	NULL
)	NULL
CAT	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
line	NULL
4	NULL
)	NULL
contains	NULL
both	NULL
the	NULL
-1290	NULL
to	NULL
-1270	NULL
and	NULL
-89	NULL
to	NULL
-38	NULL
regions	NULL
but	NULL
lacks	NULL
most	NULL
of	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
promoter/5'-flank	NULL
.	NULL

Its	NULL
serum	NULL
response	NULL
of	NULL
0.84	NULL
was	NULL
close	NULL
to	NULL
that	NULL
of	NULL
-2033	NULL
CAT	NULL
;	NULL
this	NULL
finding	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
earlier	NULL
results	NULL
,	NULL
suggests	NULL
that	NULL
all	NULL
essential	NULL
serum-regulated	NULL
elements	NULL
in	NULL
the	NULL
promoter/5'-flank	NULL
lie	NULL
in	NULL
two	NULL
regions	NULL
:	NULL
-1290	NULL
to	NULL
-1228	NULL
and	NULL
-89	NULL
to	NULL
-38	NULL
.	NULL

The	NULL
experiments	NULL
that	NULL
follow	NULL
identify	NULL
two	NULL
transcriptional	NULL
elements	NULL
within	NULL
these	NULL
regions	NULL
,	NULL
cen-tered	NULL
,	NULL
respectively	NULL
,	NULL
at	NULL
-1280	NULL
and	NULL
-65	NULL
.	NULL

The	NULL
-1280	NULL
Region	NULL
Displays	NULL
the	NULL
Functional	NULL
and	NULL
Nuclear	NULL
Factor-binding	NULL
Attributes	NULL
of	NULL
an	NULL
SRE	NULL
--	NULL
1280	NULL
is	NULL
the	NULL
center	NULL
of	NULL
a	NULL
sequence	NULL
that	NULL
resembles	NULL
the	NULL
c-fos	NULL
SRE	NULL
,	NULL
and	NULL
is	NULL
conserved	NULL
between	NULL
the	NULL
human	NULL
and	NULL
the	NULL
mouse	NULL
TSP	NULL
1	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
``	NULL
CArG	NULL
``	NULL
core	NULL
,	NULL
a	NULL
C	NULL
dinucleotide	NULL
followed	NULL
by	NULL
6	NULL
As	NULL
or	NULL
Ts	NULL
followed	NULL
by	NULL
a	NULL
G	NULL
dinucleotide	NULL
,	NULL
characteristic	NULL
of	NULL
an	NULL
SRE	NULL
,	NULL
is	NULL
conserved	NULL
among	NULL
the	NULL
three	NULL
genes	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
also	NULL
shows	NULL
the	NULL
5'-sequence	NULL
end	NULL
points	NULL
of	NULL
-1290	NULL
CAT	NULL
and	NULL
-1270	NULL
CAT	NULL
.	NULL

A	NULL
deletion	NULL
from	NULL
-1290	NULL
to	NULL
-1270	NULL
,	NULL
which	NULL
removes	NULL
most	NULL
of	NULL
the	NULL
SRE	NULL
motif	NULL
,	NULL
reduced	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
resulting	NULL
construct	NULL
to	NULL
approximately	NULL
0.15	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
compare	NULL
lines	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Trans-fection	NULL
of	NULL
-2033	NULL
(	NULL
mut	NULL
-1280	NULL
)	NULL
CAT	NULL
tested	NULL
the	NULL
function	NULL
of	NULL
the	NULL
SRE	NULL
motif	NULL
more	NULL
specifically	NULL
because	NULL
the	NULL
construct	NULL
contains	NULL
a	NULL
T	NULL
for	NULL
C	NULL
substitution	NULL
in	NULL
the	NULL
5	NULL
C	NULL
dinucleotide	NULL
of	NULL
the	NULL
SRE	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
G	NULL
complement	NULL
of	NULL
the	NULL
analogous	NULL
C	NULL
of	NULL
the	NULL
c-fos	NULL
SRE	NULL
is	NULL
the	NULL
site	NULL
of	NULL
close	NULL
interaction	NULL
between	NULL
the	NULL
SRE	NULL
and	NULL
two	NULL
of	NULL
its	NULL
direct-binding	NULL
nuclear	NULL
factors	NULL
,	NULL
including	NULL
the	NULL
serum	NULL
Construct	NULL
Serum	NULL
1	NULL
)	NULL
-2033	NULL
CAT	NULL
(	NULL
see	NULL
)	NULL
1.0	NULL
+/-	NULL
0.3	NULL
(	NULL
10	NULL
)	NULL
2033	NULL
.ds	NULL
+750	NULL
2	NULL
)	NULL
-	NULL
-2083	NULL
(	NULL
A238/-38	NULL
)	NULL
CAT	NULL
k-	NULL
on-	NULL
e	NULL
--	NULL
P—i—D	NULL
0.13	NULL
+/-	NULL
0.02	NULL
(	NULL
3	NULL
)	NULL
Pan	NULL
238	NULL
EJ	NULL
3	NULL
)	NULL
-	NULL
2033	NULL
(	NULL
A-238/-89	NULL
)	NULL
CAT	NULL
F—D—4-4Q—i—	NULL
‘	NULL
D	NULL
0.91	NULL
+/-	NULL
0.04	NULL
(	NULL
3	NULL
)	NULL
2033	NULL
``	NULL
238	NULL
#	NULL
5	NULL
4	NULL
)	NULL
-	NULL
-1307	NULL
(	NULL
A-1228/-89	NULL
)	NULL
CAT	NULL
K	NULL
D4	NULL
--	NULL
--	NULL
--	NULL
I	NULL
O—i—D	NULL
0.84	NULL
+/-	NULL
0.24	NULL
(	NULL
3	NULL
)	NULL
~1307	NULL
-	NULL
-1228	NULL
#	NULL
9	NULL
$	NULL
)	NULL
-	NULL
-2033	NULL
(	NULL
mut	NULL
1280	NULL
)	NULL
CAT	NULL
l—F—D—i—G	NULL
022	NULL
+/-	NULL
0.11	NULL
(	NULL
0	NULL
)	NULL
2033	NULL
6	NULL
)	NULL
-	NULL
2083	NULL
(	NULL
A-238/-89	NULL
;	NULL
-I-.—i——'|	NULL
:	NULL
J	NULL
0.16	NULL
+/	NULL
0.02	NULL
(	NULL
3	NULL
)	NULL
mut	NULL
-65	NULL
)	NULL
CAT	NULL
-2033	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Serum	NULL
responses	NULL
of	NULL
human	NULL
TSP1-CAT	NULL
transgenes	NULL
bearing	NULL
mutations	NULL
or	NULL
internal	NULL
deletions	NULL
.	NULL

-2033	NULL
CAT	NULL
is	NULL
duplicated	NULL
from	NULL
Fig	NULL
.	NULL

2	NULL
for	NULL
reference	NULL
.	NULL

Dotted	NULL
lines	NULL
indicate	NULL
deleted	NULL
DNA	NULL
segments	NULL
.	NULL

Other	NULL
details	NULL
are	NULL
in	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

A-	NULL
+1290	NULL
270	NULL
TSP	NULL
1	NULL
«	NULL
.	NULL

.GTGéTGAGATCCTTATTTGGTCILAGC	NULL
.	NULL

&	NULL
.	NULL

TSP	NULL
1	NULL
-1280	NULL
mutant	NULL
i	NULL
B.	NULL
c-fos	NULL
SRE	NULL
320	NULL
GGATGTCCATATTAGGACATCT	NULL
3	NULL
%	NULL
human	NULL
TSP	NULL
1	NULL
«	NULL
L289	NULL
TéAGA	NULL
'	NULL
i	NULL
‘	NULL
ééT	NULL
'	NULL
i	NULL
‘	NULL
A	NULL
'	NULL
i	NULL
‘	NULL
i	NULL
‘	NULL
TééTc	NULL
‘	NULL
AAGC	NULL
-1267	NULL
mouse	NULL
TSP	NULL
1	NULL
pn	NULL
CAAGATCCTTATTTGGTGATGC	NULL
-	NULL
»	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

A	NULL
,	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
TSP	NULL
-1280	NULL
region	NULL
,	NULL
deletion	NULL
end	NULL
points	NULL
,	NULL
and	NULL
the	NULL
-1280	NULL
mutant	NULL
.	NULL

B	NULL
,	NULL
comparison	NULL
of	NULL
c-fos	NULL
,	NULL
human	NULL
TSP	NULL
1	NULL
,	NULL
and	NULL
mouse	NULL
TSP	NULL
1	NULL
sequences	NULL
.	NULL

The	NULL
conserved	NULL
C	NULL
and	NULL
G	NULL
dinucleotides	NULL
of	NULL
the	NULL
SRE	NULL
motifs	NULL
in	NULL
all	NULL
sequences	NULL
are	NULL
in	NULL
bold	NULL
.	NULL

The	NULL
dots	NULL
indicate	NULL
identical	NULL
nucleotides	NULL
.	NULL

The	NULL
c-fos	NULL
SRE	NULL
shown	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
serum	NULL
responsiveness	NULL
upon	NULL
a	NULL
nonresponsive	NULL
promoter	NULL
(	NULL
26	NULL
)	NULL
and	NULL
conforms	NULL
closely	NULL
with	NULL
the	NULL
outlines	NULL
of	NULL
DNase	NULL
protection	NULL
by	NULL
SRF-contain-ing	NULL
nuclear	NULL
complexes	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Serum	NULL
Response	NULL
of	NULL
Thrombospondin	NULL
1	NULL
response	NULL
factor	NULL
,	NULL
SRF	NULL
(	NULL
see	NULL
``	NULL
Discussion	NULL
``	NULL
)	NULL
.	NULL

Analogous	NULL
one-base	NULL
mutations	NULL
of	NULL
the	NULL
c-fos	NULL
SRE	NULL
impair	NULL
or	NULL
abolish	NULL
binding	NULL
of	NULL
SRF	NULL
to	NULL
the	NULL
c-fos	NULL
SRE	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
shows	NULL
that	NULL
-2033	NULL
(	NULL
mut	NULL
-1280	NULL
)	NULL
CAT	NULL
yielded	NULL
a	NULL
serum	NULL
response	NULL
that	NULL
was	NULL
close	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
-1270	NULL
CAT	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
line	NULL
5	NULL
,	NULL
with	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
line	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
a	NULL
function	NULL
for	NULL
the	NULL
-1280	NULL
region	NULL
,	NULL
consistent	NULL
with	NULL
its	NULL
identity	NULL
as	NULL
an	NULL
SRE	NULL
.	NULL

We	NULL
performed	NULL
a	NULL
competition	NULL
gel-shift	NULL
assay	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
NIH-3T3	NULL
cells	NULL
,	NULL
utilizing	NULL
as	NULL
probe	NULL
a	NULL
fragment	NULL
containing	NULL
the	NULL
-1280	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
or	NULL
the	NULL
c-fos	NULL
SRE	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

The	NULL
-1280	NULL
fragment	NULL
,	NULL
the	NULL
-1280	NULL
mutant	NULL
,	NULL
the	NULL
c-fos	NULL
SRE	NULL
,	NULL
and	NULL
the	NULL
c-fos	NULL
SRE	NULL
mutant	NULL
,	NULL
pm12	NULL
,	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
.	NULL

The	NULL
pm12	NULL
mutant	NULL
is	NULL
defective	NULL
for	NULL
SRF	NULL
binding	NULL
and	NULL
for	NULL
function	NULL
in	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
(	NULL
26	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

54	NULL
,	NULL
the	NULL
-1280	NULL
fragment	NULL
,	NULL
when	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
produced	NULL
a	NULL
gel-shifted	NULL
band	NULL
that	NULL
was	NULL
competed	NULL
by	NULL
the	NULL
unlabeled	NULL
~1280	NULL
fragment	NULL
and	NULL
by	NULL
the	NULL
c-fos	NULL
SRE	NULL
,	NULL
but	NULL
not	NULL
by	NULL
the	NULL
-1280	NULL
mutant	NULL
,	NULL
nor	NULL
by	NULL
the	NULL
SRE	NULL
mutant	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
the	NULL
c-fos	NULL
SRE	NULL
,	NULL
when	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
produced	NULL
a	NULL
gel-shifted	NULL
band	NULL
that	NULL
comigrated	NULL
with	NULL
that	NULL
produced	NULL
by	NULL
the	NULL
-1280	NULL
fragment	NULL
;	NULL
this	NULL
band	NULL
shift	NULL
demonstrated	NULL
the	NULL
same	NULL
competition	NULL
pattern	NULL
as	NULL
did	NULL
the	NULL
band	NULL
shift	NULL
produced	NULL
with	NULL
the	NULL
-1280	NULL
fragment	NULL
.	NULL

These	NULL
findings	NULL
,	NULL
together	NULL
with	NULL
the	NULL
functional	NULL
data	NULL
,	NULL
establish	NULL
the	NULL
-1280	NULL
region	NULL
as	NULL
an	NULL
SRE	NULL
.	NULL

The	NULL
Serum-responsive	NULL
Function	NULL
of	NULL
the	NULL
-89	NULL
to	NULL
-38	NULL
Region	NULL
Is	NULL
Attributable	NULL
to	NULL
an	NULL
NF-	NULL
Y-binding	NULL
Site	NULL
at	NULL
-65-The	NULL
sequence	NULL
between	NULL
-89	NULL
and	NULL
-38	NULL
in	NULL
the	NULL
TSP	NULL
1	NULL
promoter	NULL
(	NULL
designated	NULL
the	NULL
-65	NULL
region	NULL
)	NULL
and	NULL
a	NULL
-65	NULL
mutant	NULL
sequence	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
.	NULL

The	NULL
-65	NULL
mutant	NULL
incorporates	NULL
substitutions	NULL
for	NULL
10	NULL
closely	NULL
contacted	NULL
nucleotides	NULL
,	NULL
determined	NULL
by	NULL
methylation	NULL
interference	NULL
analysis	NULL
of	NULL
a	NULL
gel-shifted	NULL
band	NULL
produced	NULL
by	NULL
the	NULL
-65	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
interactions	NULL
are	NULL
also	NULL
portrayed	NULL
schematically	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
and	NULL
are	NULL
compared	NULL
with	NULL
the	NULL
contacted	NULL
nucleotides	NULL
previously	NULL
established	NULL
for	NULL
the	NULL
NF-Y	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
31	NULL
)	NULL
and	NULL
for	NULL
the	NULL
CP1-binding	NULL
site	NULL
in	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
(	NULL
32	NULL
)	NULL
.	NULL

NF-Y	NULL
and	NULL
CP1	NULL
are	NULL
closely	NULL
related	NULL
,	NULL
if	NULL
not	NULL
identical	NULL
,	NULL
binding	NULL
factors	NULL
(	NULL
see	NULL
``	NULL
Discussion	NULL
``	NULL
)	NULL
.	NULL

The	NULL
three	NULL
methylation	NULL
interference	NULL
patterns	NULL
show	NULL
the	NULL
same	NULL
contacted	NULL
purines	NULL
on	NULL
both	NULL
strands	NULL
of	NULL
the	NULL
DNA	NULL
within	NULL
the	NULL
CCAAT	NULL
motif	NULL
itself	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
the	NULL
CCAAT	NULL
motif	NULL
in	NULL
TSP	NULL
1	NULL
exists	NULL
in	NULL
a	NULL
sequence	NULL
context	NULL
which	NULL
shows	NULL
additional	NULL
similarities	NULL
with	NULL
the	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
NF-Y	NULL
and	NULL
CP1	NULL
.	NULL

The	NULL
comparisons	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
B	NULL
and	NULL
C	NULL
,	NULL
led	NULL
us	NULL
to	NULL
test	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
an	NULL
NF-Y-binding	NULL
site	NULL
to	NULL
compete	NULL
with	NULL
the	NULL
-65	NULL
region	NULL
by	NULL
gel-shift	NULL
analysis	NULL
.	NULL

The	NULL
analyses	NULL
in	NULL
Fig	NULL
.	NULL

84	NULL
show	NULL
a	NULL
single	NULL
shifted	NULL
band	NULL
produced	NULL
by	NULL
the	NULL
TSP	NULL
1	NULL
-65	NULL
DNA	NULL
fragment	NULL
which	NULL
is	NULL
competed	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
-65	NULL
fragment	NULL
or	NULL
NF-Y	NULL
oligonucleotide	NULL
,	NULL
but	NULL
not	NULL
by	NULL
mutant	NULL
-65	NULL
fragment	NULL
or	NULL
by	NULL
mutant	NULL
NF-Y	NULL
oligonucleotide	NULL
.	NULL

The	NULL
NF-Y	NULL
oligonucleotide	NULL
also	NULL
yielded	NULL
a	NULL
shifted	NULL
band	NULL
that	NULL
comigrated	NULL
with	NULL
that	NULL
formed	NULL
with	NULL
the	NULL
-65	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

84	NULL
)	NULL
and	NULL
the	NULL
specific	NULL
gel-shifted	NULL
band	NULL
was	NULL
competed	NULL
by	NULL
excess	NULL
unlabeled	NULL
NF-Y	NULL
oligonucleotide	NULL
or	NULL
by	NULL
the	NULL
-65	NULL
DNA	NULL
fragment	NULL
but	NULL
not	NULL
by	NULL
their	NULL
respective	NULL
mutants	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
-65	NULL
region	NULL
contains	NULL
an	NULL
NF-Y-binding	NULL
site	NULL
;	NULL
together	NULL
with	NULL
the	NULL
severely	NULL
compromised	NULL
serum	NULL
response	NULL
observed	NULL
for	NULL
the	NULL
construct	NULL
-2033	NULL
(	NULL
A-238/-89	NULL
;	NULL
mut	NULL
-65	NULL
)	NULL
CAT	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
line	NULL
6	NULL
)	NULL
,	NULL
these	NULL
findings	NULL
demonstrate	NULL
that	NULL
the	NULL
NF-Y-binding	NULL
site	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
gene	NULL
.	NULL

The	NULL
-65	NULL
region	NULL
in	NULL
TSP	NULL
1	NULL
also	NULL
contains	NULL
a	NULL
GC	NULL
box	NULL
,	NULL
the	NULL
core	NULL
of	NULL
the	NULL
SP1	NULL
consensus	NULL
binding	NULL
site	NULL
(	NULL
39	NULL
)	NULL
,	NULL
and	NULL
CCAAT	NULL
motifs	NULL
are	NULL
part	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
characterized	NULL
for	NULL
CP2	NULL
(	NULL
40	NULL
)	NULL
,	NULL
C/EBP	NULL
(	NULL
41	NULL
)	NULL
,	NULL
and	NULL
CTF	NULL
(	NULL
42	NULL
)	NULL
,	NULL
We	NULL
therefore	NULL
wished	NULL
to	NULL
determine	NULL
whether	NULL
any	NULL
of	NULL
these	NULL
previously	NULL
characterized	NULL
transcription	NULL
factors	NULL
interacted	NULL
with	NULL
the	NULL
-65	NULL
region	NULL
of	NULL
TSP1	NULL
.	NULL

The	NULL
Serum	NULL
Response	NULL
of	NULL
Thrombospondin	NULL
1	NULL
Probe	NULL
<	NULL
--	NULL
--	NULL
--	NULL
TSP1	NULL
-1280	NULL
Competitor	NULL
_	NULL
-	NULL
|	NULL
TSPI	NULL
c-fos	NULL
|	NULL
TSPI	NULL
c-fos	NULL
-1280	NULL
|	NULL
SRE	NULL
-1280	NULL
SRE	NULL
mut	NULL
.	NULL

mut	NULL
.	NULL

Fold	NULL
excess	NULL
-	NULL
|10	NULL
100	NULL
|10	NULL
100	NULL
10	NULL
100	NULL
|	NULL
10	NULL
100	NULL
U4	NULL
«	NULL
but	NULL
is	NULL
b	NULL
#	NULL
bs	NULL
A	NULL
.	NULL

Probe	NULL
<	NULL
--	NULL
--	NULL
--	NULL
C-f08	NULL
SRE	NULL
--	NULL
--	NULL
--	NULL
>	NULL
Competitor	NULL
_	NULL
-	NULL
c-fos	NULL
TSPI	NULL
c-fos	NULL
TSPI	NULL
SRE	NULL
-1280	NULL
SRE	NULL
-1280	NULL
mut	NULL
.	NULL

mut	NULL
.	NULL

Fold	NULL
excess	NULL
-	NULL
|10	NULL
i100	NULL
|	NULL
10	NULL
100	NULL
|	NULL
10	NULL
1001	NULL
10	NULL
100	NULL
bot	NULL
--	NULL
but	NULL
bf	NULL
bub	NULL
bst	NULL
>	NULL
w	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Gel-shift	NULL
analysis	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
-1280	NULL
region	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
NIH-3T3	NULL
cells	NULL
utilizing	NULL
the	NULL
-1280	NULL
DNA	NULL
fragment	NULL
as	NULL
gel-shift	NULL
probe	NULL
in	NULL
A	NULL
and	NULL
the	NULL
c-fos	NULL
SRE	NULL
as	NULL
probe	NULL
in	NULL
B	NULL
.	NULL

The	NULL
arrow	NULL
in	NULL
B	NULL
designates	NULL
the	NULL
specific	NULL
gel-shifted	NULL
band	NULL
.	NULL

contribution	NULL
of	NULL
each	NULL
of	NULL
these	NULL
factors	NULL
to	NULL
the	NULL
binding	NULL
activity	NULL
demonstrated	NULL
by	NULL
the	NULL
-65	NULL
fragment	NULL
was	NULL
therefore	NULL
tested	NULL
by	NULL
gel-shift	NULL
analysis	NULL
.	NULL

Fig	NULL
.	NULL

9	NULL
shows	NULL
that	NULL
binding	NULL
sites	NULL
for	NULL
these	NULL
factors	NULL
failed	NULL
to	NULL
compete	NULL
with	NULL
the	NULL
-65	NULL
fragment	NULL
for	NULL
binding	NULL
to	NULL
factors	NULL
in	NULL
the	NULL
NIH-3T3	NULL
nuclear	NULL
extract	NULL
.	NULL

However	NULL
,	NULL
each	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
was	NULL
capable	NULL
of	NULL
forming	NULL
saturable	NULL
complexes	NULL
with	NULL
either	NULL
an	NULL
NIH-3T3	NULL
extract	NULL
(	NULL
SP1	NULL
,	NULL
C/EBP	NULL
,	NULL
and	NULL
CTF	NULL
)	NULL
or	NULL
a	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
(	NULL
CP2	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
,	NULL
by	NULL
exclusion	NULL
,	NULL
provide	NULL
further	NULL
support	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
NF-Y	NULL
-binding	NULL
site	NULL
in	NULL
the	NULL
-65	NULL
region	NULL
of	NULL
TSP	NULL
1	NULL
.	NULL

A	NULL
.	NULL

89	NULL
e	NULL
-38	NULL
TSP	NULL
1	NULL
-65	NULL
GCGAAGGACGGGCCGGCGGCGGGRTAACCEGCCTCCTTAGGGGTCCTTACGC	NULL
tok	NULL
-	NULL
dba	NULL
TSP	NULL
1	NULL
-65	NULL
TTCG	NULL
GAACAT	NULL
Mutant	NULL
B	NULL
\	NULL
‘	NULL
glh	NULL
vql'gn	NULL
“	NULL
ll-d	NULL
erence	NULL
:	NULL
fT	NULL
{	NULL
00	NULL
f	NULL
orr	NULL
ott	NULL
GCCCGGCCGCCGCCCATTGGCCGGAGGAAT	NULL
Ab	NULL
Ad	NULL
daa	NULL
AA	NULL
di	NULL
TSP	NULL
1	NULL
-65	NULL
tom	NULL
AACATTTTTCTGATIGGTTAAAAGTT	NULL
TTGTAAAAAGAGTAACCAATTTTCAA	NULL
Ar	NULL
dd	NULL
tot	NULL
AGGTGATTGGTTTATAG	NULL
CPI	NULL
TCCACGTARCCaAAATATC	NULL
'	NULL
M	NULL
&	NULL
A	NULL
cAdTaacc	NULL
g	NULL
}	NULL
?	NULL

C.	NULL
cceeqarcceecercerr	NULL
ec	NULL
66	NULL
€	NULL
ﬁNAq'IiAAchAANNNNNNT	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

The	NULL
TSP	NULL
1	NULL
-65	NULL
region	NULL
.	NULL

A	NULL
,	NULL
a	NULL
CCAAT	NULL
motif	NULL
(	NULL
boxed	NULL
)	NULL
and	NULL
GC	NULL
box	NULL
(	NULL
dotted	NULL
box	NULL
)	NULL
,	NULL
within	NULL
a	NULL
region	NULL
of	NULL
inverted	NULL
dyad	NULL
symmetry	NULL
centered	NULL
at	NULL
-65	NULL
(	NULL
arrows	NULL
)	NULL
,	NULL
are	NULL
shown	NULL
.	NULL

Also	NULL
shown	NULL
for	NULL
the	NULL
bottom	NULL
strand	NULL
are	NULL
base	NULL
substitutions	NULL
incorporated	NULL
in	NULL
the	NULL
-65	NULL
mutant	NULL
.	NULL

B	NULL
,	NULL
comparison	NULL
of	NULL
the	NULL
methylation	NULL
interference	NULL
pattern	NULL
of	NULL
the	NULL
-65	NULL
region	NULL
(	NULL
from	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
with	NULL
methylation	NULL
interference	NULL
analysis	NULL
of	NULL
NF-Y	NULL
(	NULL
31	NULL
)	NULL
and	NULL
CP1	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Solid	NULL
box	NULL
,	NULL
CCAAT	NULL
motif	NULL
;	NULL
filled	NULL
and	NULL
hollow	NULL
triangles	NULL
,	NULL
strong	NULL
and	NULL
weak	NULL
interference	NULL
,	NULL
respectively	NULL
;	NULL
+	NULL
,	NULL
enhanced	NULL
nuclear	NULL
factor	NULL
binding	NULL
.	NULL

C	NULL
,	NULL
comparison	NULL
of	NULL
the	NULL
-65	NULL
sequence	NULL
with	NULL
consensus	NULL
NF-Y	NULL
(	NULL
38	NULL
)	NULL
and	NULL
CP1	NULL
binding	NULL
motifs	NULL
(	NULL
32	NULL
)	NULL
.	NULL

NF-Y	NULL
Consensus	NULL
TSP	NULL
1	NULL
-65	NULL
CP1	NULL
Consensus	NULL
DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
begun	NULL
to	NULL
map	NULL
the	NULL
elements	NULL
that	NULL
mediate	NULL
the	NULL
rapid	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
TSP	NULL
1	NULL
gene	NULL
by	NULL
serum	NULL
.	NULL

The	NULL
arrangement	NULL
within	NULL
the	NULL
TSP	NULL
1	NULL
promoter	NULL
of	NULL
an	NULL
SRE	NULL
centered	NULL
at	NULL
-1280	NULL
and	NULL
an	NULL
NF-Y-binding	NULL
site	NULL
at	NULL
-65	NULL
is	NULL
in	NULL
keeping	NULL
with	NULL
the	NULL
organization	NULL
of	NULL
many	NULL
promoters	NULL
that	NULL
combine	NULL
the	NULL
function	NULL
of	NULL
a	NULL
proximal	NULL
element	NULL
with	NULL
that	NULL
of	NULL
a	NULL
more	NULL
distant	NULL
enhancer	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
most	NULL
relevant	NULL
comparison	NULL
may	NULL
be	NULL
with	NULL
the	NULL
B-actin	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
B-actin	NULL
also	NULL
requires	NULL
both	NULL
an	NULL
SRE	NULL
and	NULL
an	NULL
NF-Y-binding	NULL
site	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
spatial	NULL
arrangement	NULL
of	NULL
these	NULL
regulatory	NULL
elements	NULL
differs	NULL
from	NULL
that	NULL
in	NULL
TSP	NULL
1	NULL
.	NULL

In	NULL
B-actin	NULL
,	NULL
the	NULL
two	NULL
elements	NULL
are	NULL
closely	NULL
situated	NULL
within	NULL
a	NULL
50-bp	NULL
region	NULL
centered	NULL
at	NULL
-75	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
and	NULL
the	NULL
NF-Y-binding	NULL
site	NULL
is	NULL
upstream	NULL
of	NULL
the	NULL
SRE	NULL
.	NULL

Like	NULL
TSP	NULL
1	NULL
,	NULL
$	NULL
-actin	NULL
shows	NULL
growth	NULL
factor-response	NULL
kinetics	NULL
intermediate	NULL
between	NULL
those	NULL
of	NULL
groups	NULL
I	NULL
and	NULL
III	NULL
genes	NULL
(	NULL
9	NULL
)	NULL
,	NULL
with	NULL
transcription	NULL
and	NULL
mRNA	NULL
accumulation	NULL
peaking	NULL
15	NULL
min	NULL
and	NULL
4-8	NULL
h	NULL
,	NULL
respectively	NULL
,	NULL
post-induction	NULL
(	NULL
46	NULL
,	NULL
47	NULL
)	NULL
.	NULL

The	NULL
comparison	NULL
between	NULL
B-actin	NULL
and	NULL
TSP	NULL
1	NULL
is	NULL
considered	NULL
again	NULL
below	NULL
in	NULL
relation	NULL
to	NULL
the	NULL
functional	NULL
synergism	NULL
between	NULL
cis-acting	NULL
elements	NULL
in	NULL
transcriptional	NULL
regulation	NULL
.	NULL

An	NULL
SRE	NULL
,	NULL
at	NULL
-1280	NULL
,	NULL
Is	NULL
Involved	NULL
in	NULL
the	NULL
Serum	NULL
Response	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
Gene-The	NULL
evidence	NULL
for	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
SRE	NULL
in	NULL
TSP	NULL
1	NULL
,	NULL
and	NULL
for	NULL
its	NULL
function	NULL
in	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
gene	NULL
,	NULL
is	NULL
as	NULL
follows	NULL
.	NULL

(	NULL
a	NULL
)	NULL
A	NULL
discrete	NULL
deletion	NULL
of	NULL
the	NULL
SRE	NULL
motif	NULL
reduced	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
a	NULL
TSP-CAT	NULL
construct	NULL
by	NULL
85	NULL
%	NULL
in	NULL
stably	NULL
transfected	NULL
NIH-3T3	NULL
cells	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lines	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Mutation	NULL
of	NULL
a	NULL
single	NULL
nucleotide	NULL
in	NULL
the	NULL
preserved	NULL
CArG	NULL
box	NULL
at	NULL
the	NULL
core	NULL
of	NULL
the	NULL
SRE	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
,	NULL
a	NULL
mutation	NULL
which	NULL
has	NULL
been	NULL
found	NULL
to	NULL
reduce	NULL
or	NULL
disrupt	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
c-fos	NULL
SRE	NULL
(	NULL
37	NULL
)	NULL
,	NULL
also	NULL
reduced	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
-2033	NULL
CAT	NULL
by	NULL
about	NULL
80	NULL
%	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lines	NULL
1	NULL
and	NULL
5	NULL
)	NULL
.	NULL

(	NULL
c	NULL
)	NULL
The	NULL
TSP	NULL
-1280	NULL
element	NULL
and	NULL
the	NULL
c-fos	NULL
SRE	NULL
yielded	NULL
gel-shifted	NULL
bands	NULL
that	NULL
comigrated	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
are	NULL
therefore	NULL
likely	NULL
to	NULL
bind	NULL
the	NULL
same	NULL
nuclear	NULL
factors	NULL
in	NULL
NIH-3T3	NULL
cell	NULL
G+A	NULL
B	NULL
F	NULL
§	NULL
'	NULL
's	NULL
wank	NULL
.	NULL

ding	NULL
&	NULL
in	NULL
U	NULL
>	NULL
ao	NULL
e	NULL
€	NULL
y	NULL
C	NULL
C	NULL
T.	NULL
ls	NULL
4*A	NULL
G	NULL
‘	NULL
wan	NULL
l	NULL
A	NULL
lie	NULL
¢	NULL
-	NULL
§	NULL
y	NULL
R	NULL
lie	NULL
:	NULL
wee	NULL
G+A	NULL
Bo	NULL
F	NULL
¢	NULL
G+A	NULL
B	NULL
F	NULL
c	NULL
%	NULL
bg	NULL
§	NULL
®	NULL
C~G	NULL
c	NULL
®	NULL
~G	NULL
per	NULL
aun	NULL
.	NULL

,	NULL
U	NULL
.	NULL

%	NULL
.	NULL

are	NULL
.	NULL

m-	NULL
-	NULL
a	NULL
wk	NULL
Witte	NULL
o	NULL
3	NULL
``	NULL
|	NULL
>	NULL
(	NULL
\	NULL
,	NULL
\	NULL
.	NULL

-65	NULL
T	NULL
65	NULL
t-	NULL
A	NULL
.	NULL

&	NULL
ya	NULL
®	NULL
.	NULL

*__*	NULL
ys	NULL
i	NULL
we	NULL
®	NULL
*c	NULL
‘	NULL
ar	NULL
.	NULL

.	NULL

®	NULL
0	NULL
G	NULL
€	NULL
,	NULL
-	NULL
;	NULL
.	NULL

\e-~-	NULL
-=	NULL
©	NULL
-	NULL
®	NULL
E	NULL
Overexposure	NULL
&	NULL
\	NULL
(	NULL
;	NULL
=	NULL
wim	NULL
.	NULL

amy	NULL
.	NULL

Overexposure	NULL
m-	NULL
a	NULL
\a	NULL
»	NULL
ao	NULL
as	NULL
&	NULL
``	NULL
pe-	NULL
(	NULL
A/	NULL
\	NULL
(	NULL
‘	NULL
&	NULL
CG	NULL
wo	NULL
ag	NULL
c	NULL
&	NULL
ﬁg	NULL
~	NULL
.	NULL

we	NULL
-	NULL
hd	NULL
ge	NULL
C	NULL
.	NULL

c	NULL
-	NULL
_	NULL
owe	NULL
a*	NULL
A	NULL
C	NULL
G	NULL
foud	NULL
<	NULL
e	NULL
»	NULL
c	NULL
G	NULL
_	NULL
wan	NULL
-	NULL
aam	NULL
,	NULL
<	NULL
'\	NULL
/G	NULL
Cl	NULL
*	NULL
>	NULL
ui	NULL
0	NULL
Alk	NULL
wth	NULL
-	NULL
.	NULL

ane	NULL
C	NULL
\\	NULL
t	NULL
q	NULL
7	NULL
¢	NULL
-	NULL
@	NULL
@	NULL
an	NULL
c	NULL
c	NULL
C	NULL
**	NULL
ay	NULL
+	NULL
A	NULL
«	NULL
m	NULL
r	NULL
a	NULL
c	NULL
s1	NULL
c	NULL
@	NULL
v/	NULL
@	NULL
*	NULL
ay	NULL
«	NULL
88	NULL
§G	NULL
«	NULL
&	NULL
t	NULL
*	NULL
5	NULL
5-ATTGG-3	NULL
'	NULL
Strand	NULL
5-CCAAT-3	NULL
'	NULL
Strand	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Methylation	NULL
interference	NULL
analysis	NULL
of	NULL
the	NULL
gel-shifted	NULL
complex	NULL
formed	NULL
with	NULL
the	NULL
TSP	NULL
1	NULL
-65	NULL
fragment	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8A	NULL
.	NULL

Nucleotide	NULL
sequences	NULL
are	NULL
shown	NULL
aligned	NULL
with	NULL
gel	NULL
electro-phoretic	NULL
patterns	NULL
for	NULL
both	NULL
upper	NULL
and	NULL
lower	NULL
strands	NULL
.	NULL

Overexposures	NULL
permit	NULL
visualization	NULL
of	NULL
interference	NULL
at	NULL
the	NULL
A	NULL
nucleotides	NULL
on	NULL
both	NULL
strands	NULL
within	NULL
the	NULL
CCAAT	NULL
motif	NULL
.	NULL

G	NULL
+	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
F	NULL
designate	NULL
Maxam	NULL
and	NULL
Gilbert	NULL
G	NULL
+	NULL
A	NULL
sequencing	NULL
of	NULL
the	NULL
starting	NULL
probe	NULL
,	NULL
G	NULL
sequencing	NULL
of	NULL
factor-bound	NULL
probe	NULL
,	NULL
and	NULL
G	NULL
sequencing	NULL
of	NULL
free	NULL
probe	NULL
,	NULL
respectively	NULL
.	NULL

Filled	NULL
and	NULL
hollow	NULL
triangles	NULL
,	NULL
strong	NULL
and	NULL
weak	NULL
interference	NULL
,	NULL
respectively	NULL
;	NULL
+	NULL
,	NULL
enhanced	NULL
nuclear	NULL
factor	NULL
binding	NULL
.	NULL

extracts	NULL
.	NULL

(	NULL
d	NULL
)	NULL
A	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
SRE	NULL
(	NULL
TSP	NULL
1	NULL
-1280	NULL
)	NULL
competed	NULL
with	NULL
the	NULL
c-fos	NULL
SRE	NULL
for	NULL
nuclear	NULL
factor	NULL
binding	NULL
in	NULL
a	NULL
gel-shift	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
and	NULL
,	NULL
conversely	NULL
,	NULL
the	NULL
c-fos	NULL
SRE	NULL
effectively	NULL
competed	NULL
with	NULL
the	NULL
TSP	NULL
-1280	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

(	NULL
e	NULL
)	NULL
Mutations	NULL
in	NULL
the	NULL
-1280	NULL
element	NULL
that	NULL
reduced	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
TSP-CAT	NULL
constructs	NULL
,	NULL
and	NULL
in	NULL
the	NULL
c-fos	NULL
SRE	NULL
that	NULL
disrupted	NULL
the	NULL
binding	NULL
of	NULL
SRF	NULL
,	NULL
abolished	NULL
the	NULL
ability	NULL
of	NULL
mutated	NULL
DNA	NULL
elements	NULL
to	NULL
compete	NULL
for	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
either	NULL
the	NULL
-1280	NULL
element	NULL
or	NULL
to	NULL
the	NULL
c-fos	NULL
SRE	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
their	NULL
ability	NULL
to	NULL
mediate	NULL
serum	NULL
responsiveness	NULL
,	NULL
SREs	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
transactivation	NULL
of	NULL
genes	NULL
by	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
cycloheximide	NULL
,	NULL
epidermal	NULL
growth	NULL
factor	NULL
,	NULL
and	NULL
nerve	NULL
growth	NULL
factor	NULL
(	NULL
22	NULL
)	NULL
,	NULL
v-sre	NULL
(	NULL
48	NULL
)	NULL
,	NULL
Tax	NULL
(	NULL
49	NULL
)	NULL
,	NULL
and	NULL
casein	NULL
kinase	NULL
II	NULL
(	NULL
50	NULL
)	NULL
.	NULL

The	NULL
SRE	NULL
,	NULL
and	NULL
more	NULL
specifically	NULL
the	NULL
muscle-specific	NULL
CArG	NULL
element	NULL
,	NULL
is	NULL
also	NULL
capable	NULL
of	NULL
tranducing	NULL
signals	NULL
directing	NULL
muscle-specific	NULL
expression	NULL
and	NULL
of	NULL
mediating	NULL
transcriptional	NULL
repression	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
to	NULL
the	NULL
extent	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
gene	NULL
is	NULL
similarly	NULL
influenced	NULL
,	NULL
it	NULL
may	NULL
be	NULL
productive	NULL
to	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
the	NULL
SRE	NULL
in	NULL
other	NULL
aspects	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
gene	NULL
.	NULL

The	NULL
similar	NULL
function	NULL
of	NULL
the	NULL
SREs	NULL
in	NULL
TSP1	NULL
and	NULL
c-fos	NULL
suggests	NULL
that	NULL
studies	NULL
of	NULL
the	NULL
c-fos	NULL
SRE	NULL
and	NULL
the	NULL
identification	NULL
of	NULL
nuclear	NULL
factors	NULL
that	NULL
may	NULL
function	NULL
as	NULL
co-activators	NULL
and	NULL
accessory	NULL
proteins	NULL
in	NULL
regulation	NULL
of	NULL
c-fos	NULL
expression	NULL
(	NULL
43	NULL
)	NULL
,	NULL
may	NULL
also	NULL
be	NULL
relevant	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
TSP	NULL
1	NULL
.	NULL

Although	NULL
several	NULL
Serum	NULL
Response	NULL
of	NULL
Thrombospondin	NULL
1	NULL
Probe	NULL
<	NULL
--	NULL
-	NULL
TSP	NULL
1	NULL
-65	NULL
--	NULL
--	NULL
--	NULL
»	NULL
|NF-Y¥	NULL
Competitor	NULL
TSP	NULL
1	NULL
|	NULL
TSP	NULL
1	NULL
|	NULL
NF-Y	NULL
|	NULL
NF-Y	NULL
|	NULL
-65	NULL
-65	NULL
mut	NULL
.	NULL

mut	NULL
.	NULL

Fold	NULL
excess	NULL
-	NULL
li0	NULL
i00li0	NULL
_	NULL
i0ol	NULL
10	NULL
10	NULL
100	NULL
|	NULL
A	NULL
.	NULL

Probe	NULL
<	NULL
-	NULL
NF-Y	NULL
Competitor	NULL
-	NULL
|	NULL
NF-Y	NULL
|	NULL
NF-Y	NULL
|	NULL
TSP	NULL
1	NULL
|	NULL
TSP	NULL
1	NULL
mut	NULL
.	NULL

-65	NULL
-65	NULL
mut	NULL
.	NULL

Fold	NULL
excess	NULL
=-	NULL
10	NULL
100	NULL
]	NULL
10	NULL
100110	NULL
100	NULL
[	NULL
10	NULL
_	NULL
100	NULL
bub	NULL
s-	NULL
_	NULL
thhd	NULL
»	NULL
»	NULL
_	NULL
th	NULL
id	NULL
A	NULL
d	NULL
s	NULL
d	NULL
a	NULL
d	NULL
L	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Gel-shift	NULL
analysis	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
-65	NULL
region	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
NIH-3T3	NULL
cells	NULL
utilizing	NULL
the	NULL
-65	NULL
DNA	NULL
fragment	NULL
as	NULL
gel-shift	NULL
probe	NULL
in	NULL
A	NULL
and	NULL
the	NULL
NF-Y	NULL
binding	NULL
element	NULL
as	NULL
probe	NULL
in	NULL
A	NULL
and	NULL
B.	NULL
factors	NULL
have	NULL
been	NULL
described	NULL
that	NULL
bind	NULL
directly	NULL
to	NULL
the	NULL
c-fos	NULL
SRE	NULL
(	NULL
22	NULL
,	NULL
51	NULL
,	NULL
52	NULL
)	NULL
,	NULL
SRF	NULL
is	NULL
most	NULL
directly	NULL
implicated	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
c-fos	NULL
by	NULL
growth	NULL
factors	NULL
.	NULL

SRF	NULL
activates	NULL
transcription	NULL
of	NULL
c-fos	NULL
in	NULL
vitro	NULL
and	NULL
SRF-mediated	NULL
transcriptional	NULL
activation	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
preinitiation	NULL
complexes	NULL
that	NULL
require	NULL
only	NULL
SRF	NULL
and	NULL
a	NULL
highly	NULL
purified	NULL
TFIID	NULL
Serum	NULL
Response	NULL
of	NULL
Thrombospondin	NULL
1	NULL
Probe	NULL
<	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
TSP	NULL
1	NULL
-65	NULL
Competitor	NULL
_	NULL
-	NULL
|	NULL
SPI	NULL
CTF	NULL
|C/EBP	NULL
|	NULL
CP2	NULL
NF-Y	NULL
Fold	NULL
excess	NULL
-	NULL
|i0	NULL
100	NULL
|10	NULL
i001	NULL
10	NULL
i001	NULL
10	NULL
1001	NULL
10	NULL
100	NULL
toh	NULL
td	NULL
bak	NULL
boek	NULL
but	NULL
tab	NULL
bul	NULL
teat	NULL
bol	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Gel-shift	NULL
analysis	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
-65	NULL
region	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
NIH-3T3	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
show	NULL
the	NULL
absence	NULL
of	NULL
competition	NULL
by	NULL
SP1	NULL
,	NULL
CTF	NULL
,	NULL
C/EBP	NULL
,	NULL
and	NULL
CP2	NULL
binding	NULL
elements	NULL
.	NULL

NF-Y	NULL
was	NULL
included	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

The	NULL
-65	NULL
fragment	NULL
was	NULL
used	NULL
as	NULL
gel-shift	NULL
probe	NULL
.	NULL

preparation	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
TFIID	NULL
(	NULL
TATA-binding	NULL
protein	NULL
)	NULL
does	NULL
not	NULL
substitute	NULL
for	NULL
highly	NULL
purified	NULL
TFIID	NULL
,	NULL
a	NULL
finding	NULL
that	NULL
suggests	NULL
the	NULL
involvement	NULL
of	NULL
one	NULL
or	NULL
more	NULL
co-activators	NULL
termed	NULL
TAFs	NULL
(	NULL
TATA-binding	NULL
protein-associated	NULL
factor	NULL
)	NULL
(	NULL
54	NULL
)	NULL
.	NULL

A	NULL
Proximal	NULL
Element	NULL
,	NULL
at	NULL
-65	NULL
,	NULL
Binds	NULL
NF-Y	NULL
and	NULL
Contributes	NULL
to	NULL
the	NULL
Serum	NULL
Response	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
Gene-The	NULL
evidence	NULL
for	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
-65	NULL
element	NULL
as	NULL
an	NULL
NF-Y-binding	NULL
site	NULL
,	NULL
and	NULL
for	NULL
its	NULL
role	NULL
in	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
gene	NULL
,	NULL
is	NULL
as	NULL
follows	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Deletion	NULL
or	NULL
mutation	NULL
of	NULL
the	NULL
-65	NULL
element	NULL
reduced	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
-2033	NULL
CAT	NULL
by	NULL
about	NULL
85	NULL
%	NULL
in	NULL
stably	NULL
transfected	NULL
NIH-3T3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
compare	NULL
line	NULL
1	NULL
with	NULL
lines	NULL
2	NULL
or	NULL
6	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
The	NULL
-65	NULL
element	NULL
and	NULL
the	NULL
NF-Y	NULL
consensus	NULL
sequences	NULL
are	NULL
closely	NULL
matched	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
and	NULL
the	NULL
bases	NULL
contacted	NULL
by	NULL
the	NULL
-65	NULL
region	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
methylation	NULL
interference	NULL
analyses	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
NIH-3T3	NULL
cells	NULL
,	NULL
correspond	NULL
closely	NULL
with	NULL
those	NULL
published	NULL
for	NULL
NF-Y	NULL
(	NULL
31	NULL
)	NULL
and	NULL
CP1	NULL
(	NULL
32	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

(	NULL
c	NULL
)	NULL
The	NULL
-65	NULL
region	NULL
and	NULL
the	NULL
NF-Y	NULL
oligonucleotide	NULL
form	NULL
similar	NULL
nuclear	NULL
factor-DNA	NULL
complexes	NULL
in	NULL
a	NULL
gel-shift	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
and	NULL
are	NULL
therefore	NULL
likely	NULL
to	NULL
bind	NULL
the	NULL
same	NULL
nuclear	NULL
factors	NULL
in	NULL
NIH-3T3	NULL
cell	NULL
extracts	NULL
.	NULL

(	NULL
d	NULL
)	NULL
A	NULL
-65	NULL
region	NULL
fragment	NULL
competed	NULL
with	NULL
the	NULL
NF-Y	NULL
oligonucleotide	NULL
for	NULL
nuclear	NULL
factor	NULL
binding	NULL
in	NULL
a	NULL
gel-shift	NULL
assay	NULL
and	NULL
,	NULL
conversely	NULL
,	NULL
the	NULL
NF-Y	NULL
oligonucleotide	NULL
effectively	NULL
competed	NULL
with	NULL
the	NULL
-65	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

(	NULL
e	NULL
)	NULL
A	NULL
mutation	NULL
in	NULL
the	NULL
-65	NULL
element	NULL
that	NULL
reduced	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
TSP-CAT	NULL
constructs	NULL
and	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
NF-Y-binding	NULL
site	NULL
,	NULL
that	NULL
had	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
disrupt	NULL
NF-Y	NULL
binding	NULL
,	NULL
abolished	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
respective	NULL
binding	NULL
sites	NULL
to	NULL
compete	NULL
for	NULL
nuclear	NULL
factor	NULL
binding	NULL
in	NULL
gel-shift	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

(	NULL
f	NULL
)	NULL
Nuclear	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
-65	NULL
element	NULL
was	NULL
not	NULL
competed	NULL
by	NULL
oligonucleotides	NULL
bearing	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
other	NULL
candidate	NULL
transcription	NULL
factors	NULL
including	NULL
CTF	NULL
,	NULL
C/EBP	NULL
,	NULL
CP2	NULL
,	NULL
and	NULL
SP1	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
findings	NULL
and	NULL
the	NULL
ubiquity	NULL
of	NULL
NF-Y	NULL
(	NULL
see	NULL
below	NULL
)	NULL
we	NULL
identify	NULL
the	NULL
-65	NULL
element	NULL
as	NULL
a	NULL
component	NULL
in	NULL
the	NULL
serum	NULL
4995	NULL
response	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
gene	NULL
and	NULL
as	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
NF-Y	NULL
.	NULL

NF-Y	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
group	NULL
of	NULL
CCAAT-binding	NULL
factors	NULL
,	NULL
the	NULL
most	NULL
completely	NULL
characterized	NULL
of	NULL
which	NULL
include	NULL
mammalian	NULL
factors	NULL
«	NULL
CP1	NULL
(	NULL
55	NULL
)	NULL
,	NULL
CP1	NULL
(	NULL
32	NULL
)	NULL
,	NULL
and	NULL
CBF	NULL
(	NULL
56	NULL
)	NULL
and	NULL
yeast	NULL
factor	NULL
,	NULL
HAP	NULL
2,3,4	NULL
(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
three	NULL
mammalian	NULL
factors	NULL
have	NULL
been	NULL
characterized	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
lymphoid	NULL
cells	NULL
,	NULL
HeLa	NULL
cells	NULL
,	NULL
and	NULL
liver	NULL
.	NULL

NF-Y	NULL
binding	NULL
activity	NULL
was	NULL
identified	NULL
in	NULL
a	NULL
number	NULL
of	NULL
cells	NULL
including	NULL
macrophages	NULL
and	NULL
fibroblasts	NULL
(	NULL
58	NULL
)	NULL
,	NULL
and	NULL
its	NULL
mRNA	NULL
was	NULL
present	NULL
in	NULL
all	NULL
mouse	NULL
tissues	NULL
tested	NULL
,	NULL
including	NULL
mammary	NULL
and	NULL
salivary	NULL
glands	NULL
,	NULL
intestine	NULL
,	NULL
and	NULL
colon	NULL
(	NULL
59	NULL
)	NULL
.	NULL

The	NULL
following	NULL
observations	NULL
demonstrate	NULL
either	NULL
the	NULL
identity	NULL
or	NULL
close	NULL
relatedness	NULL
of	NULL
these	NULL
four	NULL
factors	NULL
.	NULL

Two	NULL
subunits	NULL
of	NULL
NF-Y	NULL
,	NULL
cloned	NULL
from	NULL
mouse	NULL
(	NULL
59	NULL
)	NULL
,	NULL
two	NULL
subunits	NULL
of	NULL
CBF	NULL
(	NULL
60	NULL
,	NULL
61	NULL
)	NULL
and	NULL
HAP	NULL
2	NULL
and	NULL
3	NULL
are	NULL
interspecies	NULL
homologs	NULL
of	NULL
each	NULL
other	NULL
.	NULL

Isolated	NULL
CP1	NULL
and	NULL
HAP	NULL
subunits	NULL
,	NULL
incapable	NULL
of	NULL
binding	NULL
DNA	NULL
them-selves	NULL
,	NULL
complement	NULL
each	NULL
other	NULL
when	NULL
reconstituted	NULL
to	NULL
form	NULL
DNA-binding	NULL
complexes	NULL
(	NULL
62	NULL
)	NULL
.	NULL

Binding	NULL
sites	NULL
for	NULL
«	NULL
CP1	NULL
and	NULL
CP1	NULL
cross-compete	NULL
in	NULL
gel-shift	NULL
assay	NULL
(	NULL
32	NULL
)	NULL
.	NULL

«	NULL
CP1	NULL
is	NULL
heterotri-meric	NULL
(	NULL
55	NULL
)	NULL
as	NULL
is	NULL
HAP	NULL
2,3,4	NULL
.	NULL

Recently	NULL
a	NULL
third	NULL
subunit	NULL
of	NULL
CBF	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
(	NULL
60	NULL
)	NULL
,	NULL
although	NULL
cloning	NULL
of	NULL
this	NULL
third	NULL
subunit	NULL
,	NULL
or	NULL
a	NULL
similar	NULL
one	NULL
from	NULL
NF-Y	NULL
,	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
reported	NULL
.	NULL

Last	NULL
,	NULL
NF-Y	NULL
(	NULL
31	NULL
)	NULL
,	NULL
«	NULL
CP1	NULL
(	NULL
55	NULL
)	NULL
,	NULL
CP1	NULL
(	NULL
32	NULL
)	NULL
,	NULL
and	NULL
CBF	NULL
(	NULL
63	NULL
)	NULL
are	NULL
all	NULL
intolerant	NULL
of	NULL
mutations	NULL
within	NULL
the	NULL
CCAAT	NULL
motif	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
an	NULL
«	NULL
CP1-binding	NULL
site	NULL
cross-competed	NULL
with	NULL
the	NULL
-65	NULL
fragment	NULL
of	NULL
TSP	NULL
1	NULL
in	NULL
a	NULL
gel-shift	NULL
assay	NULL
;	NULL
furthermore	NULL
,	NULL
an	NULL
«	NULL
CP1	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
CCAAT	NULL
to	NULL
CA-GAT	NULL
mutation	NULL
that	NULL
is	NULL
defective	NULL
for	NULL
«	NULL
CP1	NULL
binding	NULL
,	NULL
failed	NULL
to	NULL
cross-compete	NULL
with	NULL
the	NULL
TSP	NULL
1	NULL
-65	NULL
element	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
substitution	NULL
of	NULL
CCAAA	NULL
for	NULL
CCAAT	NULL
in	NULL
an	NULL
NF-Y-binding	NULL
site	NULL
resulted	NULL
in	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
mutant	NULL
oligonucleotide	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
TSP	NULL
1	NULL
-65	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

84	NULL
)	NULL
.	NULL

These	NULL
results	NULL
support	NULL
our	NULL
identification	NULL
of	NULL
the	NULL
TSP	NULL
-65	NULL
element	NULL
as	NULL
an	NULL
NF-Y-binding	NULL
site	NULL
and	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
requirement	NULL
of	NULL
NF-Y	NULL
for	NULL
an	NULL
intact	NULL
CCAAT	NULL
motif	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
NF-Y	NULL
,	NULL
the	NULL
transcription	NULL
factors	NULL
CP2	NULL
,	NULL
C/EBP	NULL
,	NULL
and	NULL
CTF	NULL
can	NULL
all	NULL
bind	NULL
effectively	NULL
to	NULL
sequences	NULL
that	NULL
lack	NULL
a	NULL
CCAAT	NULL
motif	NULL
.	NULL

C/EBP	NULL
binds	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
the	NULL
viral	NULL
enhancer	NULL
core	NULL
sequence	NULL
5	NULL
(	NULL
-TGTGG	NULL
(	NULL
A/T	NULL
)	NULL
(	NULL
A/T	NULL
)	NULL
(	NULL
A/T	NULL
)	NULL
G-3	NULL
'	NULL
;	NULL
the	NULL
substitution	NULL
of	NULL
GCAAT	NULL
for	NULL
CCAAT	NULL
in	NULL
a	NULL
CCAAT	NULL
motif-containing	NULL
binding	NULL
element	NULL
actually	NULL
increased	NULL
binding	NULL
affinity	NULL
(	NULL
64	NULL
)	NULL
.	NULL

The	NULL
palindrome	NULL
5'-TGG	NULL
(	NULL
A/C	NULL
)	NULL
N	NULL
,	NULL
GCCAA-3	NULL
``	NULL
'	NULL
that	NULL
forms	NULL
the	NULL
consensus	NULL
sequence	NULL
for	NULL
binding	NULL
of	NULL
CTF	NULL
(	NULL
65	NULL
)	NULL
only	NULL
occasionally	NULL
includes	NULL
a	NULL
CCAAT	NULL
motif	NULL
in	NULL
one	NULL
of	NULL
its	NULL
termini	NULL
.	NULL

CP2	NULL
also	NULL
binds	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
a	NULL
consensus	NULL
sequence	NULL
derived	NULL
from	NULL
the	NULL
mouse	NULL
«	NULL
-globin	NULL
gene	NULL
,	NULL
5-GCN	NULL
(	NULL
C/A	NULL
)	NULL
NANC	NULL
(	NULL
C/A	NULL
)	NULL
AG-3	NULL
'	NULL
,	NULL
a	NULL
sequence	NULL
that	NULL
clearly	NULL
lacks	NULL
a	NULL
CCAAT	NULL
motif	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
consensus	NULL
sequences	NULL
listed	NULL
above	NULL
are	NULL
not	NULL
well	NULL
preserved	NULL
within	NULL
the	NULL
-65	NULL
element	NULL
of	NULL
TSP	NULL
1	NULL
.	NULL

These	NULL
observations	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
failure	NULL
of	NULL
binding	NULL
sites	NULL
for	NULL
CTF	NULL
,	NULL
CP2	NULL
,	NULL
and	NULL
C/EBP	NULL
to	NULL
cross-compete	NULL
with	NULL
the	NULL
-65	NULL
fragment	NULL
in	NULL
gel-shift	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

The	NULL
SRE	NULL
and	NULL
the	NULL
NF-Y-binding	NULL
Site	NULL
Cooperate	NULL
in	NULL
the	NULL
Serum	NULL
Response	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
Gene-As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
residual	NULL
effect	NULL
of	NULL
either	NULL
the	NULL
SRE	NULL
or	NULL
NF-Y-binding	NULL
site	NULL
alone	NULL
in	NULL
mediating	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
gene	NULL
is	NULL
small	NULL
(	NULL
15-20	NULL
%	NULL
of	NULL
the	NULL
response	NULL
with	NULL
the	NULL
intact	NULL
promoter	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
elements	NULL
and	NULL
their	NULL
respective	NULL
transcription	NULL
factors	NULL
probably	NULL
interact	NULL
,	NULL
and	NULL
this	NULL
interaction	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
functionally	NULL
synergistic	NULL
.	NULL

Cooperativity	NULL
between	NULL
an	NULL
SRE	NULL
and	NULL
another	NULL
element	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
in	NULL
c-fos	NULL
(	NULL
with	NULL
a	NULL
CRE	NULL
to	NULL
mediate	NULL
the	NULL
response	NULL
to	NULL
epidermal	NULL
growth	NULL
factor	NULL
(	NULL
66	NULL
)	NULL
)	NULL
,	NULL
in	NULL
Krox	NULL
20	NULL
and	NULL
Krox	NULL
24	NULL
(	NULL
with	NULL
CREs	NULL
to	NULL
mediate	NULL
TAX	NULL
responsiveness	NULL
(	NULL
67	NULL
)	NULL
)	NULL
,	NULL
and	NULL
in	NULL
B-actin	NULL
(	NULL
with	NULL
an	NULL
NF-Y-binding	NULL
site	NULL
to	NULL
mediate	NULL
serum	NULL
responsiveness	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
)	NULL
.	NULL

In	NULL
the	NULL
cases	NULL
of	NULL
Krox	NULL
20	NULL
,	NULL
Krox	NULL
24	NULL
,	NULL
and	NULL
B-actin	NULL
,	NULL
as	NULL
in	NULL
the	NULL
case	NULL
of	NULL
TSP1	NULL
,	NULL
these	NULL
interactions	NULL
were	NULL
4996	NULL
functionally	NULL
synergistic	NULL
.	NULL

These	NULL
examples	NULL
are	NULL
illustrative	NULL
of	NULL
the	NULL
promiscuity	NULL
and	NULL
synergism	NULL
of	NULL
interactions	NULL
between	NULL
SREs	NULL
and	NULL
other	NULL
regulatory	NULL
elements	NULL
and	NULL
provide	NULL
indirect	NULL
evidence	NULL
for	NULL
the	NULL
function	NULL
of	NULL
co-activators	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
promoters	NULL
containing	NULL
SREs	NULL
,	NULL
as	NULL
suggested	NULL
by	NULL
the	NULL
models	NULL
for	NULL
transcriptional	NULL
regulation	NULL
presented	NULL
by	NULL
Lin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
68	NULL
)	NULL
.	NULL

Another	NULL
potentially	NULL
interesting	NULL
example	NULL
of	NULL
functional	NULL
promiscuity	NULL
of	NULL
the	NULL
SRE	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
mouse	NULL
TSP	NULL
1	NULL
gene	NULL
.	NULL

The	NULL
mouse	NULL
TSP	NULL
1	NULL
gene	NULL
contains	NULL
an	NULL
SRE	NULL
centered	NULL
at	NULL
-1210	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
but	NULL
lacks	NULL
a	NULL
consensus	NULL
NF-Y-binding	NULL
motif	NULL
.	NULL

Instead	NULL
,	NULL
at	NULL
-70	NULL
,	NULL
in	NULL
register	NULL
with	NULL
the	NULL
human	NULL
NF-Y-binding	NULL
site	NULL
,	NULL
the	NULL
mouse	NULL
gene	NULL
contains	NULL
a	NULL
perfect	NULL
match	NULL
with	NULL
the	NULL
consensus	NULL
sequence	NULL
for	NULL
binding	NULL
of	NULL
Egr1/Krox	NULL
24/Zif	NULL
268	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
Egr1	NULL
may	NULL
function	NULL
analogously	NULL
to	NULL
NF-Y	NULL
in	NULL
mediating	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
mouse	NULL
TSP	NULL
1	NULL
gene	NULL
.	NULL

It	NULL
is	NULL
of	NULL
interest	NULL
that	NULL
an	NULL
NF-Y-binding	NULL
site	NULL
can	NULL
be	NULL
replaced	NULL
functionally	NULL
by	NULL
AP1	NULL
,	NULL
SP1	NULL
,	NULL
or	NULL
E2-binding	NULL
sites	NULL
for	NULL
cooperation	NULL
with	NULL
an	NULL
HNF1l-binding	NULL
site	NULL
in	NULL
driving	NULL
albumin	NULL
expression	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Perhaps	NULL
,	NULL
the	NULL
divergence	NULL
of	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
TSP	NULL
1	NULL
genes	NULL
has	NULL
performed	NULL
a	NULL
related	NULL
experiment	NULL
.	NULL

Whether	NULL
serum-regulated	NULL
elements	NULL
other	NULL
than	NULL
an	NULL
SRE	NULL
and	NULL
an	NULL
NF-Y-binding	NULL
site	NULL
are	NULL
present	NULL
in	NULL
TSP	NULL
1	NULL
is	NULL
unknown	NULL
.	NULL

However	NULL
,	NULL
this	NULL
study	NULL
places	NULL
constraints	NULL
on	NULL
their	NULL
possible	NULL
lo-cation	NULL
.	NULL

The	NULL
constructs	NULL
examined	NULL
in	NULL
this	NULL
study	NULL
all	NULL
contain	NULL
an	NULL
700-bp	NULL
region	NULL
that	NULL
extends	NULL
from	NULL
+66	NULL
to	NULL
+750	NULL
,	NULL
and	NULL
includes	NULL
the	NULL
3	NULL
'	NULL
part	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
and	NULL
the	NULL
entire	NULL
first	NULL
intron	NULL
.	NULL

While	NULL
the	NULL
latter	NULL
sequences	NULL
contribute	NULL
to	NULL
the	NULL
high	NULL
level	NULL
expression	NULL
of	NULL
TSP	NULL
1-CAT	NULL
constructs	NULL
by	NULL
a	NULL
post-transcriptional	NULL
mechanism	NULL
(	NULL
23	NULL
)	NULL
,	NULL
preliminary	NULL
evidence	NULL
suggests	NULL
that	NULL
this	NULL
region	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
TSP	NULL
1	NULL
gene	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
}	NULL
.	NULL

This	NULL
observation	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
behavior	NULL
of	NULL
-1307	NULL
(	NULL
A-1228/-89	NULL
)	NULL
CAT	NULL
and	NULL
-1290	NULL
CAT	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
suggests	NULL
that	NULL
two	NULL
regions	NULL
,	NULL
-1290	NULL
to	NULL
-1228	NULL
and	NULL
-89	NULL
to	NULL
+66	NULL
,	NULL
contain	NULL
all	NULL
the	NULL
elements	NULL
within	NULL
the	NULL
-2033	NULL
to	NULL
+750	NULL
sequence	NULL
that	NULL
are	NULL
required	NULL
for	NULL
the	NULL
serum	NULL
response	NULL
of	NULL
the	NULL
human	NULL
TSP	NULL
1	NULL
gene	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Michael	NULL
Gilman	NULL
for	NULL
providing	NULL
a	NULL
number	NULL
of	NULL
reagents	NULL
,	NULL
including	NULL
the	NULL
cloned	NULL
c-fos	NULL
SRE-binding	NULL
elements	NULL
,	NULL
and	NULL
for	NULL
advice	NULL
throughout	NULL
this	NULL
project	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
DeAnn	NULL
Liska	NULL
for	NULL
providing	NULL
the	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extract	NULL
and	NULL
the	NULL
SP1-binding	NULL
element	NULL
and	NULL
DeAnn	NULL
Liska	NULL
and	NULL
Jim	NULL
Slack	NULL
for	NULL
a	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
.	NULL

Bornstein	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
FASEB	NULL
J.	NULL
,	NULL
6	NULL
,	NULL
3290-8299	NULL
.	NULL

Frazier	NULL
,	NULL
W	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Curr	NULL
.	NULL

0pm	NULL
Cell	NULL
Biol	NULL
.	NULL

3	NULL
,	NULL
792-799	NULL
.	NULL

Maj	NULL
ack	NULL
R.	NULL
A.	NULL
,	NULL
Cook	NULL
,	NULL
S.	NULL
C.	NULL
C.	NULL
,	NULL
and	NULL
Bernstein	NULL
P.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

C	NULL
U	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
9050—9054	NULL
.	NULL

Good	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Polverini	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Rastinejad	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Beau	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Lemons	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Frazier	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
and	NULL
Bouck	NULL
,	NULL
N.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
6624-6628	NULL
.	NULL

Mijack	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Goodman	NULL
,	NULL
L.	NULL
V.	NULL
,	NULL
and	NULL
Dixit	NULL
,	NULL
V.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

106	NULL
,	NULL
15-422	NULL
Sage	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
and	NULL
Bornstein	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
14831-14834	NULL
.	NULL

Mellstrom	NULL
K	NULL
Hoglund	NULL
,	NULL
A.-S.	NULL
,	NULL
Nister	NULL
,	NULL
M.	NULL
,	NULL
Heldin	NULL
,	NULL
C.-H.	NULL
,	NULL
Westermark	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Lmdberg	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
J	NULL
.	NULL

Muscle	NULL
Res	NULL
.	NULL

Cell	NULL
Motil	NULL
.	NULL

4	NULL
,	NULL
589-609	NULL
.	NULL

Bravo	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
Growth	NULL
lef	NULL
1	NULL
,	NULL
305-309	NULL
Lau	NULL
,	NULL
L	NULL
F.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
(	NULL
1991	NULL
)	NULL
in	NULL
The	NULL
Hormonal	NULL
Control	NULL
of	NULL
Gene	NULL
Transcription	NULL
(	NULL
Cohen	NULL
,	NULL
P	NULL
and	NULL
Foulkes	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
eds	NULL
)	NULL
Vol	NULL
.	NULL

6	NULL
,	NULL
pp	NULL
.	NULL

257-293	NULL
,	NULL
Elsevier	NULL
,	NULL
Amsterdam	NULL
10	NULL
.	NULL

Bornstein	NULL
,	NULL
P.	NULL
,	NULL
Devarayalu	NULL
,	NULL
S.	NULL
,	NULL
Li	NULL
,	NULL
P.	NULL
,	NULL
Disteche	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
and	NULL
Framson	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
8636-8640	NULL
11	NULL
.	NULL

Bornstein	NULL
,	NULL
P.	NULL
,	NULL
O'Rourke	NULL
,	NULL
K.	NULL
,	NULL
Wikstrom	NULL
,	NULL
K.	NULL
,	NULL
Wolf	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Katz	NULL
,	NULL
R.	NULL
,	NULL
Li	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Dixit	NULL
,	NULL
v.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL
'	NULL

Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
12821-12824	NULL
12	NULL
.	NULL

Vos	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Devarayalu	NULL
,	NULL
S.	NULL
,	NULL
de	NULL
Vries	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Bernstein	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
BioL	NULL
Chem	NULL
.	NULL

267	NULL
,	NULL
12192-	NULL
12196	NULL
13	NULL
.	NULL

Donoviel	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Framson	NULL
,	NULL
P.	NULL
,	NULL
Eldridge	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Cooke	NULL
,	NULL
M.	NULL
,	NULL
Kobayashi	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Bornstem	NULL
,	NULL
P	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Bwl	NULL
Chem	NULL
.	NULL

263	NULL
18590—18593	NULL
14	NULL
.	NULL

Laherty	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Gierman	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
Dixit	NULL
,	NULL
V.	NULL
M	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
11222—11227	NULL
ib	NULL
65	NULL
Ko	NULL
+	NULL
wp	NULL
ag	NULL
o	NULL
Serum	NULL
Response	NULL
of	NULL
Thrombospondin	NULL
1	NULL
15	NULL
.	NULL

Kobayashi	NULL
,	NULL
S.	NULL
,	NULL
Eden-McCutchan	NULL
,	NULL
F.	NULL
,	NULL
Framson	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Bornstein	NULL
,	NULL
P.	NULL
(	NULL
1986	NULL
)	NULL
Biochemistry	NULL
25	NULL
,	NULL
8418-8425	NULL
16	NULL
.	NULL

M3182	NULL
?	NULL

8132	NULL
?	NULL

Mlldbrandt	NULL
J.	NULL
,	NULL
and	NULL
Dixit	NULL
,	NULL
V.	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
17	NULL
.	NULL

Laberty	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
O'Rourke	NULL
,	NULL
K.	NULL
,	NULL
Wolf	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Katz	NULL
,	NULL
R.	NULL
,	NULL
Seldin	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Dixit	NULL
,	NULL
V.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
3274-3281	NULL
18	NULL
.	NULL

M	NULL
‘	NULL
ijggg	NULL
R.	NULL
A.	NULL
,	NULL
Cook	NULL
,	NULL
S.	NULL
C.	NULL
C.	NULL
,	NULL
and	NULL
Bornstem	NULL
,	NULL
P.	NULL
(	NULL
1985	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

101	NULL
,	NULL
1070	NULL
19	NULL
.	NULL

Asch	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Leung	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
Shapiro	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Nachman	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

83	NULL
,	NULL
2904-2008	NULL
20	NULL
.	NULL

Donoviel	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Amacher	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Judge	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
and	NULL
Bornstein	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physwl	NULL
145	NULL
16-23	NULL
21	NULL
.	NULL

Lawler	NULL
,	NULL
J.	NULL
Duquette	NULL
,	NULL
M.	NULL
,	NULL
Ferro	NULL
,	NULL
P.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
Gilbert	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Jenkms	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genmmcs	NULL
11	NULL
587-600	NULL
22	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

1	NULL
,	NULL
47-58	NULL
23	NULL
.	NULL

Bornstein	NULL
,	NULL
P.	NULL
,	NULL
Alfi	NULL
,	NULL
D.	NULL
,	NULL
Devarayalu	NULL
,	NULL
S.	NULL
,	NULL
Framson	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Li	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
16691-16698	NULL
24	NULL
.	NULL

Zoller	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

100	NULL
,	NULL
468-500	NULL
25	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
,	NULL
Second	NULL
Ed	NULL
Cold	NULL
Sprmg	NULL
Harbor	NULL
Press	NULL
,	NULL
Cold	NULL
Spung	NULL
Harbor	NULL
,	NULL
NY	NULL
26	NULL
.	NULL

Gilman	NULL
,	NULL
M.	NULL
Z	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
394-402	NULL
27	NULL
.	NULL

Melton	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Krieg	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Rebaglratl	NULL
,	NULL
T.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1984	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12	NULL
,	NULL
7035-7056	NULL
28	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
29	NULL
.	NULL

Mili	NULL
‘	NULL
lztéR	NULL
.	NULL

K.	NULL
,	NULL
Roe	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
and	NULL
Blackshear	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
576-8582	NULL
30	NULL
.	NULL

Liska	NULL
,	NULL
D.	NULL
,	NULL
Robinson	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
and	NULL
Bornstein	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Gene	NULL
Exp	NULL
.	NULL

2	NULL
,	NULL
379-389	NULL
31	NULL
.	NULL

Dorn	NULL
,	NULL
A.	NULL
,	NULL
Boliekens	NULL
,	NULL
J.	NULL
,	NULL
Staub	NULL
,	NULL
A.	NULL
,	NULL
Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
50	NULL
,	NULL
863-872	NULL
32	NULL
.	NULL

Chodosh	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Carthew	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
and	NULL
Sharp	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
563	NULL
,	NULL
11-24	NULL
33	NULL
.	NULL

Vigstén	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Sigler	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
and	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
911~	NULL
1	NULL
34	NULL
.	NULL

Kim	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Swendeman	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Barnhart	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
Sheffery	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
,	NULL
Biol	NULL
.	NULL

10	NULL
,	NULL
5958-5966	NULL
35	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
42	NULL
,	NULL
889-902	NULL
36	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
567-574	NULL
37	NULL
.	NULL

Leung	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Miyamoto	NULL
,	NULL
N.	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
1177-1195	NULL
38	NULL
.	NULL

Li	NULL
,	NULL
X.-L.	NULL
,	NULL
Hooft	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
R.	NULL
,	NULL
Mantovani	NULL
,	NULL
R.	NULL
,	NULL
Benonst	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
8984-8990	NULL
39	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.	NULL
,	NULL
Jones	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

11	NULL
,	NULL
20-23	NULL
40	NULL
.	NULL

LiglésEsg	NULL
``	NULL
Swendeman	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Sheffery	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
5	NULL
41	NULL
,	NULL
Landschulz	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Johnson	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
Adashi	NULL
,	NULL
E.	NULL
Y	NULL
Graves	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
and	NULL
McKni	NULL
ht	NULL
S.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
&	NULL
Deu	NULL
2	NULL
,	NULL
786-80	NULL
42	NULL
.	NULL

Sagtcsmé,5	NULL
Manned	NULL
N.	NULL
,	NULL
Andrews	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
and	NULL
T1181	NULL
]	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
384	NULL
,	NULL
18-224	NULL
43	NULL
.	NULL

Martin	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Bioessays	NULL
13	NULL
,	NULL
499-503	NULL
44	NULL
.	NULL

Danilition	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Frederickson	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Taylor	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
and	NULL
Miyamoto	NULL
,	NULL
N.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
6913-6922	NULL
45	NULL
.	NULL

Kawamoto	NULL
,	NULL
T.	NULL
,	NULL
Makino	NULL
,	NULL
K.	NULL
,	NULL
Orita	NULL
,	NULL
S.	NULL
,	NULL
Nakata	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kakunaga	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
523-537	NULL
46	NULL
.	NULL

Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
erf	NULL
E.	NULL
B	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nature	NULL
311	NULL
,	NULL
433-438	NULL
47	NULL
.	NULL

Leof	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
Proper	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Getz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Moses	NULL
,	NULL
H.	NULL
L.	NULL
(	NULL
1986	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

127	NULL
,	NULL
83-88	NULL
48	NULL
.	NULL

Qureshi	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Cao	NULL
,	NULL
X.	NULL
M.	NULL
,	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
and	NULL
Foster	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
10802-10806	NULL
49	NULL
.	NULL

Alexandre	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Verrier	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
543-551	NULL
50	NULL
.	NULL

Gauthier-Riviere	NULL
,	NULL
C.	NULL
,	NULL
Basset	NULL
,	NULL
M.	NULL
,	NULL
Blanchard	NULL
,	NULL
J.-M.	NULL
,	NULL
Cavadore	NULL
,	NULL
J.-C.	NULL
,	NULL
Fer-nandez	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Lamb	NULL
N.	NULL
J.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
2921-2930	NULL
51	NULL
.	NULL

Attar	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Grlman	NULL
M.	NULL
Z	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
2432-2443	NULL
52	NULL
.	NULL

Metz	NULL
,	NULL
F.	NULL
and	NULL
Ziff	NULL
,	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
2165-2178	NULL
58	NULL
.	NULL

Zhu	NULL
,	NULL
H.	NULL
,	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
Prywes	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

3	NULL
,	NULL
455-	NULL
54	NULL
.	NULL

Pugh	NULL
B.	NULL
F.	NULL
,	NULL
and	NULL
Tiian	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
679-682	NULL
55	NULL
.	NULL

Kim	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
'and	NULL
Sheffery	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
13362-13369	NULL
56	NULL
.	NULL

Hatamochl	NULL
P.	NULL
T.	NULL
,	NULL
Golumbek	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
van	NULL
Schaftingen	NULL
,	NULL
E	NULL
and	NULL
de	NULL
Crombrugghe	NULL
,	NULL
'	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
Chem	NULL
.	NULL

263	NULL
,	NULL
5940-5947	NULL
57	NULL
.	NULL

Forsberg	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Guarente	NULL
,	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1166-1178	NULL
58	NULL
.	NULL

Hooft	NULL
van	NULL
Huljsduunen	NULL
R.	NULL
,	NULL
Bollekens	NULL
J.	NULL
,	NULL
Dorn	NULL
,	NULL
A.	NULL
,	NULL
Benorst	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
,	NULL
72965-7272	NULL
59	NULL
.	NULL

Hooft	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
R.	NULL
,	NULL
Li	NULL
,	NULL
x	NULL
!	NULL

Y.	NULL
,	NULL
Black	NULL
,	NULL
D.	NULL
,	NULL
Matthes	NULL
,	NULL
H.	NULL
,	NULL
Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
'3119-3127	NULL
60	NULL
.	NULL

Maity	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Smha	NULL
S.	NULL
,	NULL
Ruteshouser	NULL
,	NULL
E	NULL
C.	NULL
,	NULL
and	NULL
de	NULL
Crombrugghe	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
16574—16580	NULL
61	NULL
.	NULL

Vuorio	NULL
,	NULL
T.	NULL
,	NULL
Maity	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
and	NULL
de	NULL
Crombrugghe	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
22480-22486	NULL
62	NULL
.	NULL

Chodosh	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Olesen	NULL
,	NULL
J.	NULL
,	NULL
Hahn	NULL
,	NULL
S.	NULL
,	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Guarente	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
83	NULL
,	NULL
25-35	NULL
63	NULL
.	NULL

Karsenty	NULL
,	NULL
G.	NULL
,	NULL
Golumbek	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
de	NULL
Crombrugghe	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263	NULL
,	NULL
13909-13915	NULL
64	NULL
.	NULL

Johnson	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
and	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

58	NULL
,	NULL
799-839	NULL
65	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Rosenfeld	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Kelly	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
79-89	NULL
R	NULL
66	NULL
.	NULL

Fisch	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Prywes	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
3490-502	NULL
3	NULL
67	NULL
.	NULL

Alexandre	NULL
C.	NULL
,	NULL
Charnay	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Verrier	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
1851-1857	NULL
68	NULL
.	NULL

Lin	NULL
,	NULL
Y.	NULL
S.	NULL
Carey	NULL
,	NULL
M.	NULL
,	NULL
Ptashne	NULL
M.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
345	NULL
,	NULL
359-361	NULL
69	NULL
.	NULL

Tronche	NULL
,	NULL
F.	NULL
,	NULL
Rollier	NULL
,	NULL
A.	NULL
,	NULL
Sourdive	NULL
,	NULL
D.	NULL
,	NULL
Cereghini	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Yaniv	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

221	NULL
,	NULL
31-43	NULL

